<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML"
	xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?>
	<front>
		<journal-meta>
			<journal-id journal-id-type="nlm-ta">AAPS PharmSciTech</journal-id>
			<journal-title-group>
				<journal-title>AAPS PharmSciTech</journal-title>
			</journal-title-group>
			<issn pub-type="epub">1530-9932</issn>
			<publisher>
				<publisher-name>Springer US</publisher-name>
				<publisher-loc>Boston</publisher-loc>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="pmid">18431651</article-id>
			<article-id pub-id-type="pmc">2976928</article-id>
			<article-id pub-id-type="publisher-id">9073</article-id>
			<article-id pub-id-type="doi">10.1208/s12249-008-9073-5</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Review Article</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>A Review of Current Intravaginal Drug Delivery
					Approaches Employed for the Prophylaxis of HIV/AIDS and Prevention
					of Sexually Transmitted Infections</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Ndesendo</surname>
						<given-names>Valence M. K.</given-names>
					</name>
					<xref ref-type="aff" rid="Aff1">1</xref>
				</contrib>
				<contrib contrib-type="author" corresp="yes">
					<name>
						<surname>Pillay</surname>
						<given-names>Viness</given-names>
					</name>
					<address>
						<phone>+27-11-7172274</phone>
						<fax>+27-11-6424355</fax>
						<email>viness.pillay@wits.ac.za</email>
					</address>
					<xref ref-type="aff" rid="Aff1">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Choonara</surname>
						<given-names>Yahya E.</given-names>
					</name>
					<xref ref-type="aff" rid="Aff1">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Buchmann</surname>
						<given-names>Eckhart</given-names>
					</name>
					<xref ref-type="aff" rid="Aff2">2</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Bayever</surname>
						<given-names>David N.</given-names>
					</name>
					<xref ref-type="aff" rid="Aff1">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Meyer</surname>
						<given-names>Leith C. R.</given-names>
					</name>
					<xref ref-type="aff" rid="Aff3">3</xref>
				</contrib>
				<aff id="Aff1">
					<label>1</label>
					Department of Pharmacy and Pharmacology, University of the
				</aff>
				<aff id="Aff2">
					<label>2</label>
					Department of Gynecology and Obstetrics
				</aff>
				<aff id="Aff3">
					<label>3</label>
					Brain Function Research Group, School of Physiology, University of
				</aff>
			</contrib-group>
			<pub-date pub-type="epub">
				<day>2</day>
				<month>4</month>
				<year>2008</year>
			</pub-date>
			<pub-date pub-type="pmc-release">
				<day>2</day>
				<month>4</month>
				<year>2008</year>
			</pub-date>
			<pub-date pub-type="collection">
				<month>6</month>
				<year>2008</year>
			</pub-date>
			<volume>9</volume>
			<issue>2</issue>
			<fpage>505</fpage>
			<lpage>520</lpage>
			<history>
				<date date-type="received">
					<day>21</day>
					<month>11</month>
					<year>2007</year>
				</date>
				<date date-type="accepted">
					<day>4</day>
					<month>2</month>
					<year>2008</year>
				</date>
			</history>
			<permissions>
				<copyright-statement>&#x000a9; American Association of
					Pharmaceutical Scientists 2008</copyright-statement>
			</permissions>
			<abstract>
				<p>
					The objective of this review is to describe the current status of
					several intravaginal anti-HIV microbicidal delivery systems these
					delivery systems and microbicidal compounds in the context of their
					stage within clinical trials and their potential cervicovaginal
					defence successes. The global Human Immuno-Deficiency Virus (HIV)
					pandemic continues to spread at a rate of more than 15,000 new
					infections daily and sexually transmitted infections (STIs) can
					predispose people to acquiring HIV infection. Male-to-female
					transmission is eight times more likely to occur than
					female-to-male transmission due to the anatomical structure of the
					vagina as well as socio-economic factors and the disempowerment of
					women that renders them unable to refuse unsafe sexual practices in
					some communities. The increased incidence of HIV in women has
					identified the urgent need for efficacious and safe intravaginal
					delivery of anti-HIV agents that can be used and controlled by
					women. To meet this challenge, several intravaginal anti-HIV
					microbicidal delivery systems are in the process of been developed.
					The outcomes of three main categories are discussed in this review:
					namely, dual-function polymeric systems, non-polymeric systems and
					nanotechnology-based systems. These delivery systems include
					formulations that modify the genital environment (e.g. polyacrylic
					acid gels and
					<italic>lactobacillus</italic>
					gels), surfactants (e.g. sodium lauryl sulfate), polyanionic
					therapeutic polymers (e.g. carageenan and carbomer/lactic acid
					gels), proteins (e.g. cyanovirin-N, monoclonal antibodies and
					thromspondin-1 peptides), protease inhibitors and other molecules
					(e.g. dendrimer based-gels and the molecular condom). Intravaginal
					microbicide delivery systems are providing a new option for
					preventing the transmission of STIs and HIV.
				</p>
			</abstract>
			<kwd-group>
				<title>Key words</title>
				<kwd>HIV/STIs</kwd>
				<kwd>intravaginal drug delivery systems</kwd>
				<kwd>microbicides</kwd>
				<kwd>nanostructures</kwd>
				<kwd>polymers</kwd>
				<kwd>prophylaxis</kwd>
			</kwd-group>
			<custom-meta-group>
				<custom-meta>
					<meta-name>issue-copyright-statement</meta-name>
					<meta-value>&#x000a9; American Association of Pharmaceutical
						Scientists 2008</meta-value>
				</custom-meta>
			</custom-meta-group>
		</article-meta>
	</front>
	<body>
		<sec id="Sec1">
			<title>INTRODUCTION</title>
			<p>
				Studies have shown that the vagina is a suitable site for local and
			</p>
		</sec>
		<sec id="Sec2" sec-type="methods">
			<title>METHODS</title>
			<p>
				Given the devastating effects of the HIV/AIDS epidemic and the
			</p>
			<sec id="Sec3">
				<title>Current Intravaginal Microbicide Delivery Methods for
					Preventing the Transmission of STIs and HIV</title>
				<p>
					The majority of microbicidal delivery systems for intravaginal
				</p>
			</sec>
			<sec id="Sec4">
				<title>Design of Intravaginal Microbicide Delivery Systems</title>
				<p>
					Intravaginal delivery may be designed for administration of
					microbicides by using an applicator or specifically designed
				</p>
			</sec>
			<sec id="Sec5">
				<title>Creams and Gels</title>
				<p>
					To date the greatest number of intravaginal drug delivery systems
				</p>
			</sec>
			<sec id="Sec6">
				<title>Tablets and Suppositories</title>
				<p>
					A large number of intravaginal delivery systems are also available
				</p>
			</sec>
			<sec id="Sec7">
				<title>Vaginal Rings</title>
				<p>
					Vaginal rings are circular ring-type drug delivery devices designed
				</p>
			</sec>
			<sec id="Sec8">
				<title>Bioadhesive Intravaginal Systems</title>
				<p>
					Most conventional intravaginal formulations however are associated
				</p>
			</sec>
		</sec>
		<sec id="Sec9">
			<title>RESULTS AND DISCUSSION</title>
			<sec id="Sec10">
				<title>Dual-Function Polymers Employed in the Design of Intravaginal
					Microbicide Delivery Systems: As Excipients with Potential
					Therapeutic Activity</title>
				<sec id="Sec11">
					<title>A Carageenan Vaginal Gel Formulation for HIV and Human
						Papilloma Virus Inhibition</title>
					<p>
						Carraguard&#x02122; is a gel-like delivery system comprising
						<table-wrap id="Tab3">
							<label>Table&#x000a0;III</label>
							<caption>
								<p>Chemical structures of polymeric microbicide compounds</p>
							</caption>
							<graphic xlink:href="12249_2008_9073_Tab1_HTML" id="MO2" />
						</table-wrap>
					</p>
				</sec>
				<sec id="Sec12">
					<title>A Combinatory Gel of Carageenan and a Non-Nucleoside Reverse
						Transcriptase Inhibitor</title>
					<p>
						PC-815 gel is an intravaginal delivery system combining a

					</p>
				</sec>
				<sec id="Sec13">
					<title>A Topical Non-Contraceptive Carageenan Gel Formulation</title>
					<p>
						PC-515 gel is a topical gel formulation containing 3%
					</p>
				</sec>
				<sec id="Sec14">
					<title>A Polyacrylic Acid-Based Gel Formulation</title>
					<p>
						A polyacrylic acid polymeric gel (BufferGel&#x02122;, ReProtect,

					</p>
				</sec>
				<sec id="Sec15">
					<title>A Lactobacillus Crispatus Soft-Gel Capsule Formulation</title>
					<p>
						A
						<italic>Lactobacillus crispatus (LC)</italic>
					</p>
				</sec>
				<sec id="Sec16">
					<title>Thermosensitive Gel Formulations</title>
					<p>
						Thermosensitive gels are systems that alter the physical
					</p>
				</sec>
				<sec id="Sec17">
					<title>Long-Chain Sulfated Polysaccharides and Sulfonated Polymeric
						Formulations</title>
					<p>
						A poly(sodium 4-styrene sulfonate) (T-PSS) and cellulose sulfate
					</p>
				</sec>
				<sec id="Sec18">
					<title>A Carbomer, Lactic Acid and Naphthalene Sulfonate Gel
						Formulation</title>
					<p>
						A gel comprising a synthetic carbomer, a lactate buffer system
					</p>
				</sec>
				<sec id="Sec19">
					<title>A Micronized Cellulose Acetate Phthalate Gel Formulation</title>
					<p>
						Cellulose Acetate Phthalate (CAP) has been used for several
					</p>
				</sec>
				<sec id="Sec20">
					<title>A Monocaprin-Loaded Hydrogel Formulation</title>
					<p>
						Monocaprin hydrogel formulations possess potent microbicidal
					</p>
				</sec>
				<sec id="Sec21">
					<title>Polystyrene Sulfonate Vaginal Tablets</title>
					<p>
						Polystyrene Sulfonate (PSS) is also a microbicide that has been
					</p>
				</sec>
			</sec>
			<sec id="Sec22">
				<title>Non-Polymeric Intravaginal Microbicide Delivery Systems for
					Preventing the Transmission of STIs and HIV</title>
				<sec id="Sec23">
					<title>A Cetyl Betaine and Myristamine Oxide Combinatory Cream
						Formulation</title>
					<p>
						C31G cream (Savvy&#x02122;, Cellegy Pharmaceuticals, Inc, San
					</p>
				</sec>
				<sec id="Sec24">
					<title>A Non-Nucleoside Reverse Transcriptase Inhibitor-Loaded Gel
						Formulation</title>
					<p>
						UC781 is a NNRTI that is incorporated into gel formulations
					</p>
				</sec>
				<sec id="Sec25">
					<title>A Nucleotide Analogue-Loaded Gel Formulation</title>
					<p>
						PMPA Gel 
					</p>
				</sec>
				<sec id="Sec26">
					<title>A Novel Synthetically Derived Aryl Phosphate-Loaded Gel
						Formulation</title>
					<p>
						Stampidine is a derivative of stavudine
					</p>
				</sec>
				<sec id="Sec27">
					<title>A Cyanovirin-N Gel Formulation for Chemotherapeutic and
						Immunoprophylactic Prevention of HIV</title>
					<p>
						Cyanovirin-N (CV-N) is a novel protein that has generated interest
					</p>
				</sec>
				<sec id="Sec28">
					<title>Sodium Lauryl Sulfate as an Invisible Condom&#x02122;
						Gel-Like Formulation</title>
					<p>
						Sodium lauryl sulfate (SLS) is currently under Phase II clinical
					</p>
				</sec>
				<sec id="Sec29">
					<title>Dapivirine Anti-HIV Vaginal Rings</title>
					<p>
						While most research on microbicides has focused on single-dose and
					</p>
				</sec>
				<sec id="Sec30">
					<title>Polyherbal Anti-HIV Praneem-Loaded Vaginal Tablets</title>
					<p>
						Praneem has been developed as an anti-HIV vaginal tablet
					</p>
				</sec>
			</sec>
			<sec id="Sec31">
				<title>Nanotechnology-Based Intravaginal Microbicide Delivery
					Systems</title>
				<sec id="Sec32">
					<title>A Dendrimer-Based Microbicide Formulation</title>
					<p>
						SPL2008 (VivaGel&#x02122;, Starpharma Ltd., Melbourne, Victoria,
					</p>
				</sec>
				<sec id="Sec33">
					<title>Silver Nanoparticles Employed as Microbicide Delivery
						Systems</title>
					<p>
						Various studies are currently investigating the production of a
					</p>
				</sec>
				<sec id="Sec34">
					<title>Polystyrene Nanospheres as Microbicide Delivery Systems</title>
					<p>
						Mucosal secretory IgA may have an important role in the prevention
					</p>
				</sec>
				<sec id="Sec35">
					<title>A Gel-Like Molecular Condom Formulation as a Barrier for
						STIs and HIV Transmission</title>
					<p>
						The molecular condom is a recently developed anti-HIV vaginal gel
					</p>
				</sec>
			</sec>
			<sec id="Sec36">
				<title>Other Microbicidal Compounds Currently Under Investigation</title>
				<sec id="Sec37">
					<title>Thiophen-Thiourea: A Non-Nucleoside Reverse Transcriptase
						Inhibitor</title>
					<p>
						PHI-443 is a rationally designed novel thiophen&#x02013;thiourea
					</p>
				</sec>
				<sec id="Sec38">
					<title>A Secretory Leukocyte Protease Inhibitor</title>
					<p>
						Secretory leukocyte protease inhibitor (SLPI) is an endogenous
						
					</p>
				</sec>
				<sec id="Sec39">
					<title>Monoclonal Antibodies as Microbicides</title>
					<p>
						Monoclonal antibodies are molecules synthesized by the immune
					</p>
				</sec>
				<sec id="Sec40">
					<title>Thrombospondin-1 as a Barrier to Mucosal Transmission of
						HIV-1</title>
					<p>
						During an investigation of the physiology of HIV inhibition by
					</p>
				</sec>
				<sec id="Sec41">
					<title>Short Interfering RNA as Potential Liposomal Microbicide
						Delivery Systems</title>
					<p>
						Short interfering RNA (siRNA) is a type of microbicide based on
					</p>
				</sec>
				<sec id="Sec42">
					<title>Lime Juice as a Microbicide</title>
					<p>

					</p>
				</sec>
				<sec id="Sec43">
					<title>Yoghurt as a Microbicide</title>
					<p>

					</p>
				</sec>
			</sec>
		</sec>
		<sec id="Sec44">
			<title>CONCLUSIONS</title>
			<p>Intravaginal microbicide delivery systems are providing a new and
				microbicidal delivery.</p>
		</sec>
	</body>
	<back>
		<ack>
			<title>Acknowledgements</title>
			<p>Grants from the Norwegian Agency for Development Co-operation
				(NORAD) and the Faculty Research Committee of the University of the
				Witwatersrand, Johannesburg, South Africa are acknowledged.</p>
		</ack>
		<ref-list id="Bib1">
			<title>References</title>
			<ref id="CR1">
				<label>1.</label>
				<mixed-citation publication-type="other">
					HIV and its transmission. Division of HIV/AIDS Prevention, 2003.
					Available at:
					<italic>Center for Disease Control and Prevention.</italic>
					Accessed May 23, 2006.
				</mixed-citation>
			</ref>
			<ref id="CR2">
				<label>2.</label>
				<mixed-citation publication-type="other">
					How HIV is spread. San Francisco AIDS Foundation. Available at:
					<ext-link ext-link-type="uri" xlink:href="http://www.iapac.org">www.iapac.org</ext-link>
					. Accessed May 23, 2006.
				</mixed-citation>
			</ref>
			<ref id="CR3">
				<label>3.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Pusch</surname>
							<given-names>O.</given-names>
						</name>
						<name>
							<surname>Boden</surname>
							<given-names>D.</given-names>
						</name>
						<name>
							<surname>Hannify</surname>
							<given-names>S.</given-names>
						</name>
						<name>
							<surname>Lee</surname>
							<given-names>F.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Bioengineering lactic acid bacteria to secrete the
						HIV-1 virucide cyanovirin</article-title>
					<source>J. AIDS</source>
					<year>2005</year>
					<volume>40</volume>
					<issue>5</issue>
					<fpage>512</fpage>
					<lpage>520</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR4">
				<label>4.</label>
				<mixed-citation publication-type="other">
					Overview of the global AIDS epidemic. Report on the global AIDS
					epidemic, UNAIDS/WHO. Available at:
					<ext-link ext-link-type="uri"
						xlink:href="http://www.cmaj.ca/cgi/content/full/176/12/172">http://www.cmaj.ca/cgi/content/full/176/12/172</ext-link>
					. Accessed June 8, 2006.
				</mixed-citation>
			</ref>
			<ref id="CR5">
				<label>5.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Pisani</surname>
							<given-names>E.</given-names>
						</name>
						<name>
							<surname>Garnett</surname>
							<given-names>G. P.</given-names>
						</name>
						<name>
							<surname>Grassly</surname>
							<given-names>N. C.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Back to basics in HIV prevention: focus on exposure</article-title>
					<source>BMJ</source>
					<year>2003</year>
					<volume>326</volume>
					<fpage>1384</fpage>
					<lpage>1387</lpage>
					<pub-id pub-id-type="doi">10.1136/bmj.326.7403.1384</pub-id>
					<pub-id pub-id-type="pmid">12816830</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR6">
				<label>6.</label>
				<mixed-citation publication-type="other">
					K. R. Malcolm, and D. A. Woolfson. Delivery hope on HIV-Vaginal
					rings for controlled release of microbicides.
					<italic>J Controlled Release</italic>
					. 52&#x02013;55 (2006).
				</mixed-citation>
			</ref>
			<ref id="CR7">
				<label>7.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Berger</surname>
							<given-names>J.</given-names>
						</name>
					</person-group>
					<article-title>Re-sexualizing the Epidemic: Desire, risk and HIV
						prevention</article-title>
					<source>Dev. Update</source>
					<year>2004</year>
					<volume>5</volume>
					<issue>3</issue>
					<fpage>45</fpage>
					<lpage>67</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR8">
				<label>8.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Brown</surname>
							<given-names>T. J.</given-names>
						</name>
						<name>
							<surname>Yen-Moore</surname>
							<given-names>A.</given-names>
						</name>
						<name>
							<surname>Trying</surname>
							<given-names>S. K.</given-names>
						</name>
					</person-group>
					<article-title>An overview of sexually transmitted diseases. Part 1</article-title>
					<source>J. Am. Acad. Dermatol.</source>
					<year>1999</year>
					<volume>41</volume>
					<issue>4</issue>
					<fpage>511</fpage>
					<lpage>532</lpage>
					<pub-id pub-id-type="pmid">10495370</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR9">
				<label>9.</label>
				<mixed-citation publication-type="other">
					Sexually transmitted infections (STIs). Drug Digest, 2004.
					Available at:
					<ext-link ext-link-type="uri"
						xlink:href="http://www.drugdigest.org/DD/PrintablePages/HealthConditions/1,20041,550367,00.html">http://www.drugdigest.org/DD/PrintablePages/HealthConditions/1,20041,550367,00.html</ext-link>
					. Accessed April 20, 2007.
				</mixed-citation>
			</ref>
			<ref id="CR10">
				<label>10.</label>
				<mixed-citation publication-type="other">
					Sexually transmitted Infections (STIs) as a public health issue.
					Facts sheets, WHO, 2004. Available at:
					<ext-link ext-link-type="uri"
						xlink:href="http://www.who.int/reproductive-health/stis/docs/sti_factsheet_2004.pdf">http://www.who.int/reproductive-health/stis/docs/sti_factsheet_2004.pdf</ext-link>
					. Accessed April 22, 2007.
				</mixed-citation>
			</ref>
			<ref id="CR11">
				<label>11.</label>
				<mixed-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Reddy</surname>
							<given-names>S. P.</given-names>
						</name>
						<name>
							<surname>Swart</surname>
							<given-names>D.</given-names>
						</name>
						<name>
							<surname>Jinabhai</surname>
							<given-names>C. C.</given-names>
						</name>
						<name>
							<surname>Amosun</surname>
							<given-names>S. L.</given-names>
						</name>
						<name>
							<surname>James</surname>
							<given-names>S.</given-names>
						</name>
						<name>
							<surname>Monyeki</surname>
							<given-names>K. D.</given-names>
						</name>
						<name>
							<surname>Stevens</surname>
							<given-names>G.</given-names>
						</name>
						<name>
							<surname>Morejele</surname>
							<given-names>N.</given-names>
						</name>
						<name>
							<surname>Kambaram</surname>
							<given-names>N. S.</given-names>
						</name>
						<name>
							<surname>Omardien</surname>
							<given-names>R. G.</given-names>
						</name>
						<name>
							<surname>Borne</surname>
							<given-names>H. W.</given-names>
						</name>
					</person-group>
					<source>Umthenthe Uhlaba Usamila &#x02013; The South African Youth
						Risk Behaviour Survey 2002</source>
					<year>2003</year>
					<publisher-loc>Cape Town</publisher-loc>
					<publisher-name>South African Medical Research Council</publisher-name>
				</mixed-citation>
			</ref>
			<ref id="CR12">
				<label>12.</label>
				<mixed-citation publication-type="other">
					A. E. Pettifor, H. V. Rees, A. Steffenson, L. Hlongwa-Madikizela,
					C. MacPhail, K. Vermaak, and I. Kleinschmidt. HIV and sexual
					behavior among young South Africans: a national survey of
					15&#x02013;24&#x000a0;year olds. Reproductive Health Research Unit,
					University of the Witwatersrand. Available at
					<ext-link ext-link-type="uri"
						xlink:href="http://www.rhruco.za/images/Docs/national%20survey%20RHRU.pdf">http://www.rhruco.za/images/Docs/national%20survey%20RHRU.pdf</ext-link>
					. Accessed November, 2007.
				</mixed-citation>
			</ref>
			<ref id="CR13">
				<label>13.</label>
				<mixed-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Hatcher</surname>
							<given-names>R.</given-names>
						</name>
						<etal />
					</person-group>
					<source>Contraceptive Technology</source>
					<year>2004</year>
					<edition>18</edition>
					<publisher-loc>Inc., New York</publisher-loc>
					<publisher-name>Ardent Media</publisher-name>
				</mixed-citation>
			</ref>
			<ref id="CR14">
				<label>14.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Weber</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Desai</surname>
							<given-names>K.</given-names>
						</name>
						<name>
							<surname>Darbyshire</surname>
							<given-names>J.</given-names>
						</name>
					</person-group>
					<article-title>The development of vaginal microbicides for the
						prevention of HIV transmission</article-title>
					<source>PLoS Medicine</source>
					<year>2005</year>
					<volume>2</volume>
					<issue>5</issue>
					<fpage>0392</fpage>
					<lpage>0395</lpage>
					<pub-id pub-id-type="doi">10.1371/journal.pmed.0020142</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR16">
				<label>16.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Katz</surname>
							<given-names>D. F.</given-names>
						</name>
						<name>
							<surname>Dunmire</surname>
							<given-names>E. N.</given-names>
						</name>
						<name>
							<surname>Henderson</surname>
							<given-names>M. H.</given-names>
						</name>
						<name>
							<surname>Owen</surname>
							<given-names>D. H.</given-names>
						</name>
						<name>
							<surname>Plenys</surname>
							<given-names>A. M.</given-names>
						</name>
					</person-group>
					<article-title>Applications of biomedical engineering in
						reproductive biomedicine: sensing and drug delivery to the lower
						female reproductive tract</article-title>
					<source>Eng. Med. Biol. Soc.</source>
					<year>1997</year>
					<volume>6 and 30</volume>
					<fpage>2656</fpage>
					<lpage>2658</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR20">
				<label>20.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Al-Tahami</surname>
							<given-names>K.</given-names>
						</name>
						<name>
							<surname>Singh</surname>
							<given-names>J.</given-names>
						</name>
					</person-group>
					<article-title>Smart polymer based delivery systems for peptides
						and proteins</article-title>
					<source>Recent Patents on Drug Delivery and Formulation</source>
					<year>2007</year>
					<volume>1</volume>
					<issue>1</issue>
					<fpage>65</fpage>
					<lpage>71</lpage>
					<pub-id pub-id-type="doi">10.2174/187221107779814113</pub-id>
					<pub-id pub-id-type="pmid">19075875</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR21">
				<label>21.</label>
				<mixed-citation publication-type="other">C. W. Lew.
					Controlled release pH sensitive capsule and adhesive system and
					method. US Patent 5364634 (1994).</mixed-citation>
			</ref>
			<ref id="CR22">
				<label>22.</label>
				<mixed-citation publication-type="other">C. Bogentoft, and A.
					Carlsson. Gel forming liquid carrier composition. US Patent 5492937
					(1996).</mixed-citation>
			</ref>
			<ref id="CR25">
				<label>25.</label>
				<mixed-citation publication-type="other">
					HIV Vaginal Gel: An overview of PRO 2000. Mom A. Available at:
					<ext-link ext-link-type="uri"
						xlink:href="http://www.associatedcontent.com/article/92443/HIV_vaginal_gel_an_overview_of_pro.html">http://www.associatedcontent.com/article/92443/HIV_vaginal_gel_an_overview_of_pro.html</ext-link>
					. Accessed March 24, 2006.
				</mixed-citation>
			</ref>
			<ref id="CR31">
				<label>31.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Moore</surname>
							<given-names>J. P.</given-names>
						</name>
						<name>
							<surname>Shattock</surname>
							<given-names>R. J.</given-names>
						</name>
					</person-group>
					<article-title>Preventing HIV-1 sexual transmission&#x02014;not
						sexy enough science, or no benefit to the bottom line?</article-title>
					<source>J. Antimicrob. Chemother.</source>
					<year>2003</year>
					<volume>52</volume>
					<fpage>890</fpage>
					<lpage>892</lpage>
					<pub-id pub-id-type="doi">10.1093/jac/dkh011</pub-id>
					<pub-id pub-id-type="pmid">14613946</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR35">
				<label>35.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Nikolic</surname>
							<given-names>D. S.</given-names>
						</name>
						<name>
							<surname>Garcia</surname>
							<given-names>E.</given-names>
						</name>
						<name>
							<surname>Piguet</surname>
							<given-names>V.</given-names>
						</name>
					</person-group>
					<article-title>Microbicides and other topical agents in the
						prevention of HIV and sexually transmitted infections</article-title>
					<source>Future Drugs</source>
					<year>2007</year>
					<volume>5</volume>
					<issue>1</issue>
					<fpage>77</fpage>
					<lpage>88</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR39">
				<label>39.</label>
				<mixed-citation publication-type="other">
					A molecular condom against AIDS. P. Kiser. Available at:
					<ext-link ext-link-type="uri"
						xlink:href="http://unews.utah.edu/p/?r=111706&#x02013;2, 1&#x02013;3">http://unews.utah.edu/p/?r=111706&#x02013;2,
						1&#x02013;3</ext-link>
					. Accessed March 26, 2007.
				</mixed-citation>
			</ref>
			<ref id="CR41">
				<label>41.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Herrewege</surname>
							<given-names>Y. V.</given-names>
						</name>
						<name>
							<surname>Michiels</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Roey</surname>
							<given-names>J.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>
						<italic>In vitro</italic>
						evaluation of non-nucleoside reverse transcriptase inhibitors
						UC-781 and TMC120-R147681 as human immunodeficiency virus
						microbicides
					</article-title>
					<source>Antimicrob Agents Chemother.</source>
					<year>2004</year>
					<volume>48</volume>
					<fpage>337</fpage>
					<lpage>339</lpage>
					<pub-id pub-id-type="doi">10.1128/AAC.48.1.337-339.2004</pub-id>
					<pub-id pub-id-type="pmid">14693562</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR43">
				<label>43.</label>
				<mixed-citation publication-type="other">
					D. Mitchel. Focus renewed on HIV microbicides.
					<italic>International Health Conference, Canada</italic>
					, 2006.
				</mixed-citation>
			</ref>
			<ref id="CR46">
				<label>46.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>El-Kamel</surname>
							<given-names>A.</given-names>
						</name>
						<name>
							<surname>Soker</surname>
							<given-names>M.</given-names>
						</name>
						<name>
							<surname>Naggar</surname>
							<given-names>V.</given-names>
						</name>
						<name>
							<surname>Al Gamal</surname>
							<given-names>S.</given-names>
						</name>
					</person-group>
					<article-title>Chitosan and sodium alginate-based bioadhesive
						vaginal tablets</article-title>
					<source>AAPS PharmSciTech.</source>
					<year>2002</year>
					<volume>4</volume>
					<issue>4</issue>
					<fpage>1</fpage>
					<lpage>8</lpage>
					<pub-id pub-id-type="doi">10.1208/ps040419</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR47">
				<label>47.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Gavin</surname>
							<given-names>E.</given-names>
						</name>
						<name>
							<surname>Sanna</surname>
							<given-names>V.</given-names>
						</name>
						<name>
							<surname>Juliano</surname>
							<given-names>C.</given-names>
						</name>
						<name>
							<surname>Benfero</surname>
							<given-names>C. M.</given-names>
						</name>
						<name>
							<surname>Giunchedi</surname>
							<given-names>P.</given-names>
						</name>
					</person-group>
					<article-title>Mucoadhesive vaginal tablets as veterinary system
						for the controlled release of an antimicrobial drug, acriflavine</article-title>
					<source>AAPS PharmSciTech.</source>
					<year>2002</year>
					<volume>3</volume>
					<issue>3</issue>
					<fpage>1</fpage>
					<lpage>7</lpage>
					<pub-id pub-id-type="doi">10.1007/BF02830615</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR48">
				<label>48.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Laarhoven</surname>
							<given-names>J. A. H.</given-names>
						</name>
						<name>
							<surname>Kruft</surname>
							<given-names>M. A. B.</given-names>
						</name>
						<name>
							<surname>Vromans</surname>
							<given-names>H.</given-names>
						</name>
					</person-group>
					<article-title>
						<italic>In vitro</italic>
						release properties of etonogestrol and ethinyl estradiol from a
						contraceptive vaginal ring
					</article-title>
					<source>Int. J. Pharm.</source>
					<year>2002</year>
					<volume>232</volume>
					<issue>1</issue>
					<fpage>163</fpage>
					<lpage>173</lpage>
					<pub-id pub-id-type="doi">10.1016/S0378-5173(01)00900-0</pub-id>
					<pub-id pub-id-type="pmid">11790500</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR49">
				<label>49.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Harrison</surname>
							<given-names>P. F.</given-names>
						</name>
						<name>
							<surname>Rosenberg</surname>
							<given-names>Z.</given-names>
						</name>
						<name>
							<surname>Bowcut</surname>
							<given-names>J.</given-names>
						</name>
					</person-group>
					<article-title>Topical microbicides for disease prevention: Status
						and challenges</article-title>
					<source>Clin. Infect. Dis.</source>
					<year>2003</year>
					<volume>26</volume>
					<fpage>1290</fpage>
					<lpage>1294</lpage>
					<pub-id pub-id-type="doi">10.1086/374834</pub-id>
					<pub-id pub-id-type="pmid">12746775</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR50">
				<label>50.</label>
				<mixed-citation publication-type="other">
					L. van Damme. Alliance for microbicide development.
					<italic>Health and Sexuality Microbicides</italic>
					. Special report, 1&#x02013;8 (2002).
				</mixed-citation>
			</ref>
			<ref id="CR51">
				<label>51.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Damme</surname>
							<given-names>L.</given-names>
						</name>
						<name>
							<surname>Adriens</surname>
							<given-names>E.</given-names>
						</name>
						<name>
							<surname>Ramjee</surname>
							<given-names>G.</given-names>
						</name>
					</person-group>
					<article-title>The evaluation of the local tolerance of vaginal
						formulations with or without nonxynolol-9 using the slug mucosal
						irritation test</article-title>
					<source>Contraception</source>
					<year>2002</year>
					<volume>66</volume>
					<issue>5</issue>
					<fpage>369</fpage>
					<lpage>375</lpage>
					<pub-id pub-id-type="doi">10.1016/S0010-7824(02)00433-X</pub-id>
					<pub-id pub-id-type="pmid">12443969</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR52">
				<label>52.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>D&#x02019;Cruz</surname>
							<given-names>O. J.</given-names>
						</name>
						<name>
							<surname>UcKun</surname>
							<given-names>F. M.</given-names>
						</name>
					</person-group>
					<article-title>Clinical development of microbicides for the
						prevention of HIV infection</article-title>
					<source>Curr. Pharm. Design</source>
					<year>2004</year>
					<volume>10</volume>
					<issue>3</issue>
					<fpage>315</fpage>
					<lpage>335</lpage>
					<pub-id pub-id-type="doi">10.2174/1381612043386374</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR53">
				<label>53.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Johnson</surname>
							<given-names>V. E.</given-names>
						</name>
						<name>
							<surname>Masters</surname>
							<given-names>W. H.</given-names>
						</name>
					</person-group>
					<article-title>Intravaginal contraceptive study: Phase I. Anatomy</article-title>
					<source>West. J. Surg. Obstet. Gynecol.</source>
					<year>1962</year>
					<volume>70</volume>
					<fpage>202</fpage>
					<lpage>207</lpage>
					<pub-id pub-id-type="pmid">14452114</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR54">
				<label>54.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Katz</surname>
							<given-names>D. F.</given-names>
						</name>
						<name>
							<surname>Dunmire</surname>
							<given-names>E. N.</given-names>
						</name>
						<name>
							<surname>Henderson</surname>
							<given-names>M. H.</given-names>
						</name>
						<name>
							<surname>Owen</surname>
							<given-names>D. H.</given-names>
						</name>
						<name>
							<surname>Plenys</surname>
							<given-names>A. M.</given-names>
						</name>
					</person-group>
					<article-title>Applications of biomedical engineering in
						reproductive biomedicine: sensing and drug delivery to the lower
						female reproductive tract</article-title>
					<source>Engineering in Medicine and Biology society</source>
					<year>1997</year>
					<volume>6 and 30</volume>
					<fpage>2656</fpage>
					<lpage>2658</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR55">
				<label>55.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>DuBouchet</surname>
							<given-names>L.</given-names>
						</name>
						<name>
							<surname>McGregor</surname>
							<given-names>J. A.</given-names>
						</name>
						<name>
							<surname>Ismail</surname>
							<given-names>M.</given-names>
						</name>
						<name>
							<surname>McCormack</surname>
							<given-names>W. M.</given-names>
						</name>
					</person-group>
					<article-title>
						A pilot study of metronidazole vaginal gel versus oral
						metronidazole for the treatment of
						<italic>trichomonas vaginalis</italic>
						vaginitis
					</article-title>
					<source>Sex. Transm. Dis.</source>
					<year>1998</year>
					<volume>25</volume>
					<fpage>176</fpage>
					<lpage>179</lpage>
					<pub-id pub-id-type="doi">10.1097/00007435-199803000-00012</pub-id>
					<pub-id pub-id-type="pmid">9524997</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR56">
				<label>56.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lamont</surname>
							<given-names>R. F.</given-names>
						</name>
						<name>
							<surname>Jones</surname>
							<given-names>B. M.</given-names>
						</name>
						<name>
							<surname>Mandal</surname>
							<given-names>D.</given-names>
						</name>
						<name>
							<surname>Hay</surname>
							<given-names>P. E.</given-names>
						</name>
						<name>
							<surname>Sheehan</surname>
							<given-names>M.</given-names>
						</name>
					</person-group>
					<article-title>The efficacy of vaginal clindamycin for the
						treatment of abnormal genital tract flora in pregnancy</article-title>
					<source>Infect. Dis. Obstet. Gynecol.</source>
					<year>2003</year>
					<volume>11</volume>
					<fpage>181</fpage>
					<lpage>189</lpage>
					<pub-id pub-id-type="doi">10.1080/10647440300025519</pub-id>
					<pub-id pub-id-type="pmid">15108863</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR57">
				<label>57.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Owen</surname>
							<given-names>D. H.</given-names>
						</name>
						<name>
							<surname>Dunmire</surname>
							<given-names>E. N.</given-names>
						</name>
						<name>
							<surname>Planys</surname>
							<given-names>A. M.</given-names>
						</name>
						<name>
							<surname>Katz</surname>
							<given-names>D. F.</given-names>
						</name>
					</person-group>
					<article-title>Factors influencing nonoxynol-9 permeation and
						bioactivity in cervical mucus</article-title>
					<source>J. Control Release</source>
					<year>1999</year>
					<volume>60</volume>
					<fpage>23</fpage>
					<lpage>34</lpage>
					<pub-id pub-id-type="doi">10.1016/S0168-3659(99)00017-6</pub-id>
					<pub-id pub-id-type="pmid">10370168</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR58">
				<label>58.</label>
				<mixed-citation publication-type="other">S. Yiv, M. Li, O.
					D&#x02019;Cruz, and F. M. Uckun. Gel-microencapsulation
					formulations. USP Patent 064114, June 20, 2006.</mixed-citation>
			</ref>
			<ref id="CR59">
				<label>59.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Paavonen</surname>
							<given-names>J.</given-names>
						</name>
					</person-group>
					<article-title>Physiology and ecology of the vagina</article-title>
					<source>Scand. J. Infect. Dis.</source>
					<year>1983</year>
					<volume>40</volume>
					<fpage>31</fpage>
					<lpage>35</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR60">
				<label>60.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Cajander</surname>
							<given-names>S. S.</given-names>
						</name>
						<name>
							<surname>Rylander</surname>
							<given-names>E.</given-names>
						</name>
					</person-group>
					<article-title>Morphometric characteristics of the vaginal
						epithelium during the menstrual cycle</article-title>
					<source>Gynecol Obstet. Invest.</source>
					<year>1988</year>
					<volume>26</volume>
					<fpage>136</fpage>
					<lpage>144</lpage>
					<pub-id pub-id-type="doi">10.1159/000293685</pub-id>
					<pub-id pub-id-type="pmid">2851505</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR61">
				<label>61.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Pschera</surname>
							<given-names>H.</given-names>
						</name>
						<name>
							<surname>Hjerpe</surname>
							<given-names>A.</given-names>
						</name>
						<name>
							<surname>Carlstrom</surname>
							<given-names>K.</given-names>
						</name>
					</person-group>
					<article-title>Influence of the maturity of the vaginal epithelium
						upon the absorption of vaginally administered estradiol-17-b and
						progesterone in postmenopausal women</article-title>
					<source>Gynecol. Obstet. Invest.</source>
					<year>1989</year>
					<volume>27</volume>
					<fpage>204</fpage>
					<lpage>207</lpage>
					<pub-id pub-id-type="doi">10.1159/000293657</pub-id>
					<pub-id pub-id-type="pmid">2744624</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR62">
				<label>62.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Katz</surname>
							<given-names>D. F.</given-names>
						</name>
						<name>
							<surname>Dunmire</surname>
							<given-names>E. N.</given-names>
						</name>
					</person-group>
					<article-title>Cervical mucus. Problems and opportunities for drug
						delivery via the vagina and cervix</article-title>
					<source>Adv. Drug Deliv. Rev.</source>
					<year>1993</year>
					<volume>11</volume>
					<fpage>385</fpage>
					<lpage>401</lpage>
					<pub-id pub-id-type="doi">10.1016/0169-409X(93)90017-X</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR63">
				<label>63.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Klavinskis</surname>
							<given-names>L. S.</given-names>
						</name>
						<name>
							<surname>Daheshia</surname>
							<given-names>M.</given-names>
						</name>
						<name>
							<surname>Karem</surname>
							<given-names>K.</given-names>
						</name>
						<name>
							<surname>Manickan</surname>
							<given-names>E.</given-names>
						</name>
						<name>
							<surname>Rouse</surname>
							<given-names>B. T.</given-names>
						</name>
					</person-group>
					<article-title>Intranasal immunization with plasmid DNA-lipid
						complexes elicits mucosal immunity in the female genital and
						rectal and rectal tracts</article-title>
					<source>J. Immunol.</source>
					<year>1999</year>
					<volume>1</volume>
					<fpage>254</fpage>
					<lpage>262</lpage>
					<pub-id pub-id-type="pmid">9886393</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR64">
				<label>64.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Woolfson</surname>
							<given-names>A. D.</given-names>
						</name>
						<name>
							<surname>Malcom</surname>
							<given-names>R. K.</given-names>
						</name>
						<name>
							<surname>Morrow</surname>
							<given-names>R. J.</given-names>
						</name>
						<name>
							<surname>Tonner</surname>
							<given-names>C. F.</given-names>
						</name>
						<name>
							<surname>Mc Cullag</surname>
							<given-names>S. D.</given-names>
						</name>
					</person-group>
					<article-title>Intravaginal ring delivery of the reverse
						transcriptase inhibitor TMC 120 as an HIV microbicides</article-title>
					<source>Int J Pharm.</source>
					<year>2006</year>
					<volume>325</volume>
					<issue>1&#x02013;2</issue>
					<fpage>82</fpage>
					<lpage>89</lpage>
					<pub-id pub-id-type="doi">10.1016/j.ijpharm.2006.06.026</pub-id>
					<pub-id pub-id-type="pmid">16884869</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR65">
				<label>65.</label>
				<mixed-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Washington</surname>
							<given-names>N.</given-names>
						</name>
						<name>
							<surname>Washington</surname>
							<given-names>C.</given-names>
						</name>
						<name>
							<surname>Wilson</surname>
							<given-names>C. G.</given-names>
						</name>
					</person-group>
					<person-group person-group-type="editor">
						<name>
							<surname>Washington</surname>
							<given-names>N.</given-names>
						</name>
						<name>
							<surname>Washington</surname>
							<given-names>C.</given-names>
						</name>
						<name>
							<surname>Wilson</surname>
							<given-names>C. G.</given-names>
						</name>
					</person-group>
					<article-title>Vaginal and intrauterine drug delivery</article-title>
					<source>Physiological Pharmaceutics: Barriers to Drug Absorption</source>
					<year>2001</year>
					<publisher-loc>London</publisher-loc>
					<publisher-name>Taylor and Francis</publisher-name>
					<fpage>271</fpage>
					<lpage>281</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR66">
				<label>66.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Roumen</surname>
							<given-names>F. J. M. E.</given-names>
						</name>
						<name>
							<surname>Dieben</surname>
							<given-names>T. O. M.</given-names>
						</name>
					</person-group>
					<article-title>Clinical acceptability of an ethylene-vinyl-acetate
						non-medicated vaginal ring</article-title>
					<source>Contraception</source>
					<year>1999</year>
					<volume>59</volume>
					<fpage>59</fpage>
					<lpage>62</lpage>
					<pub-id pub-id-type="doi">10.1016/S0010-7824(98)00145-0</pub-id>
					<pub-id pub-id-type="pmid">10342086</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR67">
				<label>67.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Nov&#x000e1;k</surname>
							<given-names>C.</given-names>
						</name>
						<name>
							<surname>Loge</surname>
							<given-names>L.</given-names>
						</name>
						<name>
							<surname>Meulen</surname>
							<given-names>E. A.</given-names>
						</name>
					</person-group>
					<article-title>The combined contraceptive vaginal ring, NuvaRing:
						an international study of user acceptability</article-title>
					<source>Contraception</source>
					<year>2003</year>
					<volume>67</volume>
					<fpage>187</fpage>
					<lpage>194</lpage>
					<pub-id pub-id-type="doi">10.1016/S0010-7824(02)00514-0</pub-id>
					<pub-id pub-id-type="pmid">12618252</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR68">
				<label>68.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Harwood</surname>
							<given-names>B.</given-names>
						</name>
						<name>
							<surname>Mishell</surname>
							<given-names>D. R.</given-names>
						</name>
					</person-group>
					<article-title>Contraceptive vaginal ring</article-title>
					<source>Semin. Reprod. Med.</source>
					<year>2001</year>
					<volume>19</volume>
					<fpage>381</fpage>
					<lpage>390</lpage>
					<pub-id pub-id-type="doi">10.1055/s-2001-18646</pub-id>
					<pub-id pub-id-type="pmid">11727180</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR69">
				<label>69.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ballagh</surname>
							<given-names>S. A.</given-names>
						</name>
					</person-group>
					<article-title>Vaginal ring hormone delivery systems in
						contraception and menopause</article-title>
					<source>Clin. Obstet. Gynecol.</source>
					<year>2001</year>
					<volume>44</volume>
					<fpage>106</fpage>
					<lpage>113</lpage>
					<pub-id pub-id-type="doi">10.1097/00003081-200103000-00014</pub-id>
					<pub-id pub-id-type="pmid">11219238</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR70">
				<label>70.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Dezarnaulds</surname>
							<given-names>G.</given-names>
						</name>
						<name>
							<surname>Fraser</surname>
							<given-names>I. S.</given-names>
						</name>
					</person-group>
					<article-title>Vaginal ring delivery of hormone replacement
						therapy&#x02014;a review</article-title>
					<source>Expt. Opin. Pharmacother.</source>
					<year>2002</year>
					<volume>4</volume>
					<fpage>201</fpage>
					<lpage>212</lpage>
					<pub-id pub-id-type="doi">10.1517/14656566.4.2.201</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR71">
				<label>71.</label>
				<mixed-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Richardson</surname>
							<given-names>J. L.</given-names>
						</name>
						<name>
							<surname>Armstrong</surname>
							<given-names>T. I.</given-names>
						</name>
					</person-group>
					<person-group person-group-type="editor">
						<name>
							<surname>Mathiowitz</surname>
							<given-names>E.</given-names>
						</name>
						<name>
							<surname>Chickering</surname>
							<given-names>D. E.</given-names>
						</name>
						<name>
							<surname>Lehr</surname>
							<given-names>C. M.</given-names>
						</name>
					</person-group>
					<article-title>Vaginal delivery of calcitonin by hyaluronic acid
						formulations</article-title>
					<source>Bioadhesive Drug Delivery Systems: Fundamentals, Novel
						Approaches and Development</source>
					<year>1999</year>
					<publisher-loc>New York</publisher-loc>
					<publisher-name>Marcel Dekker</publisher-name>
					<fpage>563</fpage>
					<lpage>599</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR72">
				<label>72.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hwang</surname>
							<given-names>S.</given-names>
						</name>
						<name>
							<surname>Wada</surname>
							<given-names>E. O.</given-names>
						</name>
						<name>
							<surname>Yotsuanagi</surname>
							<given-names>T.</given-names>
						</name>
						<name>
							<surname>Suhardja</surname>
							<given-names>I.</given-names>
						</name>
						<name>
							<surname>Ho</surname>
							<given-names>N. F. H.</given-names>
						</name>
						<name>
							<surname>Flynn</surname>
							<given-names>G. L.</given-names>
						</name>
						<name>
							<surname>Higuchi</surname>
							<given-names>W. I.</given-names>
						</name>
					</person-group>
					<article-title>
						Systems approach to vaginal delivery of drugs: II.
						<italic>In situ</italic>
						vaginal absorption of unbranched aliphatic alcohols
					</article-title>
					<source>J. Pharm. Sci.</source>
					<year>1977</year>
					<volume>65</volume>
					<fpage>1574</fpage>
					<lpage>1578</lpage>
					<pub-id pub-id-type="doi">10.1002/jps.2600651105</pub-id>
					<pub-id pub-id-type="pmid">993988</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR73">
				<label>73.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Brannon-Peppas</surname>
							<given-names>L.</given-names>
						</name>
					</person-group>
					<article-title>Novel vaginal drug release applications</article-title>
					<source>Adv. Drug Deliv. Rev.</source>
					<year>1992</year>
					<volume>11</volume>
					<fpage>169</fpage>
					<lpage>177</lpage>
					<pub-id pub-id-type="doi">10.1016/0169-409X(93)90031-X</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR74">
				<label>74.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sanders</surname>
							<given-names>J. M.</given-names>
						</name>
						<name>
							<surname>Matthews</surname>
							<given-names>H. B.</given-names>
						</name>
					</person-group>
					<article-title>Vaginal absorption of polyvinyl alcohol in Fischer
						344 rats</article-title>
					<source>Human Exp. Toxicol.</source>
					<year>1990</year>
					<volume>9</volume>
					<fpage>71</fpage>
					<lpage>77</lpage>
					<pub-id pub-id-type="doi">10.1177/096032719000900202</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR75">
				<label>75.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Woodley</surname>
							<given-names>J.</given-names>
						</name>
					</person-group>
					<article-title>Bioadhesion: new possibilities for drug adhesion?</article-title>
					<source>Clin. Pharmacokinet.</source>
					<year>2001</year>
					<volume>40</volume>
					<fpage>77</fpage>
					<lpage>84</lpage>
					<pub-id pub-id-type="doi">10.2165/00003088-200140020-00001</pub-id>
					<pub-id pub-id-type="pmid">11286325</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR76">
				<label>76.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Knuth</surname>
							<given-names>K.</given-names>
						</name>
						<name>
							<surname>Amiji</surname>
							<given-names>M.</given-names>
						</name>
						<name>
							<surname>Robinson</surname>
							<given-names>J. R.</given-names>
						</name>
					</person-group>
					<article-title>Hydrogel delivery systems for vaginal and oral
						applications: formulation and biological consideration</article-title>
					<source>Adv. Drug Deliv. Rev.</source>
					<year>1993</year>
					<volume>11</volume>
					<fpage>137</fpage>
					<lpage>164</lpage>
					<pub-id pub-id-type="doi">10.1016/0169-409X(93)90030-8</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR77">
				<label>77.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ceschel</surname>
							<given-names>G. C.</given-names>
						</name>
						<name>
							<surname>Maffei</surname>
							<given-names>P.</given-names>
						</name>
						<name>
							<surname>Borgia</surname>
							<given-names>S. L.</given-names>
						</name>
						<name>
							<surname>Ronchi</surname>
							<given-names>C.</given-names>
						</name>
						<name>
							<surname>Rossi</surname>
							<given-names>S.</given-names>
						</name>
					</person-group>
					<article-title>Development of a mucoadhesive dosage form for
						vaginal administration</article-title>
					<source>Drug Dev. Ind. Pharm.</source>
					<year>2001</year>
					<volume>27</volume>
					<fpage>541</fpage>
					<lpage>547</lpage>
					<pub-id pub-id-type="doi">10.1081/DDC-100105179</pub-id>
					<pub-id pub-id-type="pmid">11548861</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR78">
				<label>78.</label>
				<mixed-citation publication-type="other">
					S. Garg, K. Verman, R. A. Anderson, and L. J. Zaneveld. Rapidly
					disintegrating novel bioadhesive vaginal tablets of polystyrene
					sulfonate (PSS), a potential microbicide formulation [abstract]
					<italic>. International Conference of AIDS</italic>
					[serial online]. 2004; Abstract TuPeB4656.
				</mixed-citation>
			</ref>
			<ref id="CR79">
				<label>79.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Perotti</surname>
							<given-names>M.</given-names>
						</name>
						<name>
							<surname>Pirovano</surname>
							<given-names>A.</given-names>
						</name>
						<name>
							<surname>Phillips</surname>
							<given-names>D. M.</given-names>
						</name>
					</person-group>
					<article-title>Carageenan formulation prevents macrophage
						trafficking from vagina: Implications for microbicide development</article-title>
					<source>Biol. Reprod.</source>
					<year>2003</year>
					<volume>69</volume>
					<issue>3</issue>
					<fpage>933</fpage>
					<lpage>939</lpage>
					<pub-id pub-id-type="doi">10.1095/biolreprod.102.014555</pub-id>
					<pub-id pub-id-type="pmid">12773428</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR80">
				<label>80.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lee</surname>
							<given-names>C. H.</given-names>
						</name>
						<name>
							<surname>Bagdon</surname>
							<given-names>R.</given-names>
						</name>
						<name>
							<surname>Chien</surname>
							<given-names>Y. W.</given-names>
						</name>
					</person-group>
					<article-title>
						Comparative
						<italic>in vitro</italic>
						spermicidal activity and synergistic effect of chelating agents
						with nonoxynol-9 on human sperm functionality
					</article-title>
					<source>J. Pharm. Sci.</source>
					<year>1996</year>
					<volume>85</volume>
					<fpage>91</fpage>
					<lpage>95</lpage>
					<pub-id pub-id-type="doi">10.1021/js9501876</pub-id>
					<pub-id pub-id-type="pmid">8926592</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR81">
				<label>81.</label>
				<mixed-citation publication-type="other">W. R. Blakemore, A.
					D. Ballard, C. J. Sewall, J. J. Modliszewski, and W. A. Bubnis.
					Inventors. Carageenan based antimicrobial compositions. US Patent
					0171053 (2005).</mixed-citation>
			</ref>
			<ref id="CR82">
				<label>82.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Smit</surname>
							<given-names>A. J.</given-names>
						</name>
					</person-group>
					<article-title>Medicinal and pharmaceutical uses of seaweed natural
						products: A review</article-title>
					<source>J. App. Psych.</source>
					<year>2004</year>
					<volume>16</volume>
					<issue>4</issue>
					<fpage>245</fpage>
					<lpage>262</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR83">
				<label>83.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Pearce-Pratt</surname>
							<given-names>R.</given-names>
						</name>
						<name>
							<surname>Phillips</surname>
							<given-names>D. M.</given-names>
						</name>
					</person-group>
					<article-title>Sulfated polysaccharides inhibit
						lymphocyte-to-epithelial transmission of human immunodeficiency
						virus-1</article-title>
					<source>Biol. Reprod.</source>
					<year>1996</year>
					<volume>54</volume>
					<issue>1</issue>
					<fpage>173</fpage>
					<lpage>182</lpage>
					<pub-id pub-id-type="doi">10.1095/biolreprod54.1.173</pub-id>
					<pub-id pub-id-type="pmid">8838015</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR84">
				<label>84.</label>
				<mixed-citation publication-type="other">
					A. Forbes, and P. Harrison. Microbicides
					<italic>. Aids Community Research Initiative</italic>
					. America (2000).
				</mixed-citation>
			</ref>
			<ref id="CR85">
				<label>85.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Justin-Temu</surname>
							<given-names>M.</given-names>
						</name>
						<name>
							<surname>Damian</surname>
							<given-names>F.</given-names>
						</name>
						<name>
							<surname>Kinget</surname>
							<given-names>R.</given-names>
						</name>
						<name>
							<surname>Mooter</surname>
							<given-names>G.</given-names>
						</name>
					</person-group>
					<article-title>Intravaginal gels as drug delivery systems</article-title>
					<source>J. Women&#x02019;s Health</source>
					<year>2004</year>
					<volume>31</volume>
					<issue>7</issue>
					<fpage>834</fpage>
					<lpage>843</lpage>
					<pub-id pub-id-type="doi">10.1089/jwh.2004.13.834</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR86">
				<label>86.</label>
				<mixed-citation publication-type="other">
					N. Coetzee, A. Hoosen, K. Blanchard, A. de Kock, H. Sebda, B.
					Friedland, C. Ellerton, N. Nkompela, L Altin, G Ndlovu and K
					Tweedy. Safety of lambda carageenan microbicides
					(Carraguard&#x02122;) in South Africa.
					<italic>University of Cape Town, Medical University of Southern
						Africa, Population Council and Family Health International.</italic>
					2006. Available at:
					<ext-link ext-link-type="uri"
						xlink:href="http://www.itg.be/micro2002/downloads/presentations/2Monday_May_13_2002/Track_B_sessions/Nicol_Coetzee.pdf">http://www.itg.be/micro2002/downloads/presentations/2Monday_May_13_2002/Track_B_sessions/Nicol_Coetzee.pdf</ext-link>
					. Accessed October 17, 2007.
				</mixed-citation>
			</ref>
			<ref id="CR87">
				<label>87.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Fern&#x000e1;ndez-Romero Jos&#x000e9;</surname>
							<given-names>A.</given-names>
						</name>
						<name>
							<surname>Mitchell</surname>
							<given-names>T.</given-names>
						</name>
						<name>
							<surname>Stuart</surname>
							<given-names>G.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Carrageenan/MIV-150 (PC-815), a combination
						microbicide</article-title>
					<source>Sex. Transm. Dis.</source>
					<year>2007</year>
					<volume>34</volume>
					<issue>1</issue>
					<fpage>9</fpage>
					<lpage>14</lpage>
					<pub-id pub-id-type="doi">10.1097/01.olq.0000223287.46097.4b</pub-id>
					<pub-id pub-id-type="pmid">16924181</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR88">
				<label>88.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Buck</surname>
							<given-names>B. C.</given-names>
						</name>
						<name>
							<surname>Thompson</surname>
							<given-names>C. D.</given-names>
						</name>
						<name>
							<surname>Roberts</surname>
							<given-names>J. N.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Carageenan is a potent inhibitor of papillomavirus
						infection</article-title>
					<source>PloS Pathogens</source>
					<year>2006</year>
					<volume>2</volume>
					<issue>2</issue>
					<fpage>0671</fpage>
					<lpage>0680</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR89">
				<label>89.</label>
				<mixed-citation publication-type="other">
					B. M. Finley, C. J. Plescia, P. F. Harrison, and F. N. Vignes. An
					analytical overview of the microbicide preclinical and clinical
					pipeline.
					<italic>AIDS Conference. Toronto Canada;</italic>
					August, 2006.
				</mixed-citation>
			</ref>
			<ref id="CR90">
				<label>90.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Zacharopoulos</surname>
							<given-names>V. R.</given-names>
						</name>
						<name>
							<surname>Phillips</surname>
							<given-names>D. M.</given-names>
						</name>
					</person-group>
					<article-title>Vaginal formulations of carrageenan protect mice
						from herpes simplex virus infection</article-title>
					<source>Clin. Diag. Lab. Immunol.</source>
					<year>1997</year>
					<volume>4</volume>
					<issue>4</issue>
					<fpage>465</fpage>
					<lpage>468</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR91">
				<label>91.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Maria-Elisa</surname>
							<given-names>P.</given-names>
						</name>
						<name>
							<surname>Pirovano</surname>
							<given-names>A.</given-names>
						</name>
						<name>
							<surname>Phillips</surname>
							<given-names>D. M.</given-names>
						</name>
					</person-group>
					<article-title>Carageenan formulation prevents macrophage
						trafficking from vagina: Implications for microbicide development</article-title>
					<source>Biol. Reprod.</source>
					<year>2003</year>
					<volume>69</volume>
					<issue>3</issue>
					<fpage>933</fpage>
					<lpage>939</lpage>
					<pub-id pub-id-type="doi">10.1095/biolreprod.102.014555</pub-id>
					<pub-id pub-id-type="pmid">12773428</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR92">
				<label>92.</label>
				<mixed-citation publication-type="other">
					A. Verhelst.
					<italic>BMC Microbiology</italic>
					. (5)61):DOI 10.1186/1471-2180-5-61 (2005).
				</mixed-citation>
			</ref>
			<ref id="CR93">
				<label>93.</label>
				<mixed-citation publication-type="other">
					E. A. Boskey, M. Jansen, I. K. Merski, I. T. Whaley, T. Moench, and
					R. Cone. BufferGel&#x02122; favors
					<italic>in vitro</italic>
					growth of lactobacilli while inhibiting BV-associated organisms
					[abstract].
					<italic>Johns Hopkins University and ReProtect, Inc.</italic>
					[serial online]. Abstract A07 (2000).
				</mixed-citation>
			</ref>
			<ref id="CR94">
				<label>94.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Boskey</surname>
							<given-names>E. R.</given-names>
						</name>
						<name>
							<surname>Cone</surname>
							<given-names>R. A.</given-names>
						</name>
						<name>
							<surname>Whaley</surname>
							<given-names>K. J.</given-names>
						</name>
						<name>
							<surname>Moench</surname>
							<given-names>T. R.</given-names>
						</name>
					</person-group>
					<article-title>Origin of vaginal acidity: High D/L lactate ratio is
						consistent with bacteria being the primary source</article-title>
					<source>Hum. Reprod.</source>
					<year>2001</year>
					<volume>16</volume>
					<issue>9</issue>
					<fpage>1809</fpage>
					<lpage>1813</lpage>
					<pub-id pub-id-type="doi">10.1093/humrep/16.9.1809</pub-id>
					<pub-id pub-id-type="pmid">11527880</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR95">
				<label>95.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Wijgert</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Fullem</surname>
							<given-names>A.</given-names>
						</name>
						<name>
							<surname>Kelly</surname>
							<given-names>G.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Phase I trial of the topical microbicide buffer gel:
						Safety results from four international sites</article-title>
					<source>J. AIDS</source>
					<year>2001</year>
					<volume>26</volume>
					<issue>1</issue>
					<fpage>21</fpage>
					<lpage>27</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR96">
				<label>96.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>D&#x02019;Cruz</surname>
							<given-names>O. J.</given-names>
						</name>
						<name>
							<surname>Samuel</surname>
							<given-names>P.</given-names>
						</name>
						<name>
							<surname>Uckun</surname>
							<given-names>F. M.</given-names>
						</name>
					</person-group>
					<article-title>PHI-443): A novel noncontraceptive broad-spectrum
						anti-human immunodeficiency virus microbicide</article-title>
					<source>Biol. Reprod.</source>
					<year>2004</year>
					<volume>71</volume>
					<issue>6</issue>
					<fpage>2037</fpage>
					<lpage>2047</lpage>
					<pub-id pub-id-type="doi">10.1095/biolreprod.104.032870</pub-id>
					<pub-id pub-id-type="pmid">15306558</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR97">
				<label>97.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Amarl</surname>
							<given-names>E.</given-names>
						</name>
						<name>
							<surname>Perdigao</surname>
							<given-names>A.</given-names>
						</name>
						<name>
							<surname>Souza</surname>
							<given-names>M. H.</given-names>
						</name>
						<name>
							<surname>Mauck</surname>
							<given-names>C.</given-names>
						</name>
						<name>
							<surname>Waller</surname>
							<given-names>D.</given-names>
						</name>
						<name>
							<surname>Zaneveld</surname>
							<given-names>L.</given-names>
						</name>
						<name>
							<surname>Faundes</surname>
							<given-names>A.</given-names>
						</name>
					</person-group>
					<article-title>Postcoital testing after the use of acid buffering
						gel (ACIDFORM) and a 2% nonoxynol-9 product</article-title>
					<source>Contraception</source>
					<year>2004</year>
					<volume>70</volume>
					<issue>6</issue>
					<fpage>492</fpage>
					<lpage>497</lpage>
					<pub-id pub-id-type="doi">10.1016/j.contraception.2004.06.007</pub-id>
					<pub-id pub-id-type="pmid">15541412</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR98">
				<label>98.</label>
				<mixed-citation publication-type="other">M. J. Durrani.
					Prolonged release bioadhesive vaginal gel dosage form. US Patent
					6159491 (2000).</mixed-citation>
			</ref>
			<ref id="CR99">
				<label>99.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kast</surname>
							<given-names>C. E.</given-names>
						</name>
						<name>
							<surname>Valenta</surname>
							<given-names>C.</given-names>
						</name>
						<name>
							<surname>Leopold</surname>
							<given-names>M.</given-names>
						</name>
						<name>
							<surname>Bernkop-Schn&#x000fc;rch</surname>
							<given-names>A.</given-names>
						</name>
					</person-group>
					<article-title>Design and in vitro evaluation of a novel
						bioadhesive vaginal drug delivery system for clotrimazole</article-title>
					<source>J. Control Rel.</source>
					<year>2002</year>
					<volume>81</volume>
					<issue>3</issue>
					<fpage>347</fpage>
					<lpage>354</lpage>
					<pub-id pub-id-type="doi">10.1016/S0168-3659(02)00077-9</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR100">
				<label>100.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mosher</surname>
							<given-names>D. F.</given-names>
						</name>
					</person-group>
					<article-title>Physiology of thrombospondin</article-title>
					<source>Annu. Rev. Med.</source>
					<year>1990</year>
					<volume>41</volume>
					<fpage>85</fpage>
					<lpage>89</lpage>
					<pub-id pub-id-type="doi">10.1146/annurev.me.41.020190.000505</pub-id>
					<pub-id pub-id-type="pmid">1691903</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR101">
				<label>101.</label>
				<mixed-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Okada</surname>
							<given-names>H.</given-names>
						</name>
					</person-group>
					<person-group person-group-type="editor">
						<name>
							<surname>Lee</surname>
							<given-names>V. H. L.</given-names>
						</name>
					</person-group>
					<article-title>Vaginal route of peptide and protein delivery</article-title>
					<source>Peptide and Protein Drug Delivery</source>
					<year>1991</year>
					<publisher-loc>New York</publisher-loc>
					<publisher-name>Marcel Dekker</publisher-name>
					<fpage>633</fpage>
					<lpage>666</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR102">
				<label>102.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sappey</surname>
							<given-names>C.</given-names>
						</name>
						<name>
							<surname>Boelaert</surname>
							<given-names>J. R.</given-names>
						</name>
						<name>
							<surname>Legrandpoels</surname>
							<given-names>S.</given-names>
						</name>
						<name>
							<surname>Grady</surname>
							<given-names>R. W.</given-names>
						</name>
						<name>
							<surname>Piette</surname>
							<given-names>J.</given-names>
						</name>
					</person-group>
					<article-title>NF-kB transcription factor activation by hydrogen
						peroxide can be decreased by 2,3-dihydroxybenzoic acid and its
						ethyl ester derivative</article-title>
					<source>Arch. Biochem. Biophy.</source>
					<year>1995</year>
					<volume>321</volume>
					<issue>1</issue>
					<fpage>263</fpage>
					<lpage>270</lpage>
					<pub-id pub-id-type="doi">10.1006/abbi.1995.1394</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR103">
				<label>103.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Simoes</surname>
							<given-names>J. A.</given-names>
						</name>
						<name>
							<surname>Citron</surname>
							<given-names>D. M.</given-names>
						</name>
						<name>
							<surname>Aroutcheva</surname>
							<given-names>A.</given-names>
						</name>
						<name>
							<surname>Anderson</surname>
							<given-names>R. A.</given-names>
						</name>
						<name>
							<surname>Chany</surname>
							<given-names>C. J.</given-names>
						</name>
						<name>
							<surname>Waller</surname>
							<given-names>D. P.</given-names>
						</name>
						<name>
							<surname>Faro</surname>
							<given-names>S.</given-names>
						</name>
						<name>
							<surname>Zaneveld</surname>
							<given-names>L. J. D.</given-names>
						</name>
					</person-group>
					<article-title>
						Two novel vaginal microbicides (Polystyrene sulfonate and
						cellulose sulfate) inhibit
						<italic>Gardnerella vaginalis</italic>
						and anaerobes commonly associated with bacterial vaginosis
					</article-title>
					<source>Antimicrob. Agents Chemother.</source>
					<year>2002</year>
					<volume>46</volume>
					<issue>8</issue>
					<fpage>2692</fpage>
					<lpage>2695</lpage>
					<pub-id pub-id-type="doi">10.1128/AAC.46.8.2692-2695.2002</pub-id>
					<pub-id pub-id-type="pmid">12121959</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR104">
				<label>104.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Anderson</surname>
							<given-names>R. A.</given-names>
						</name>
						<name>
							<surname>Feathergill</surname>
							<given-names>K. A.</given-names>
						</name>
						<name>
							<surname>Diao</surname>
							<given-names>X. H.</given-names>
						</name>
						<name>
							<surname>Cooper</surname>
							<given-names>M. D.</given-names>
						</name>
						<name>
							<surname>Kirkpatrick</surname>
							<given-names>R.</given-names>
						</name>
						<name>
							<surname>Spear</surname>
							<given-names>P.</given-names>
						</name>
						<name>
							<surname>Waller</surname>
							<given-names>D. P.</given-names>
						</name>
						<name>
							<surname>Chany</surname>
							<given-names>C. J.</given-names>
						</name>
						<name>
							<surname>Doncel</surname>
							<given-names>G. F.</given-names>
						</name>
						<name>
							<surname>Herold</surname>
							<given-names>B. C.</given-names>
						</name>
						<name>
							<surname>Zaneveld</surname>
							<given-names>D. L. J.</given-names>
						</name>
					</person-group>
					<article-title>Evaluation of poly (styrene-4-sulfonate) as a
						preventive agent for conception and sexually transmitted diseases</article-title>
					<source>J. Androl.</source>
					<year>2000</year>
					<volume>21</volume>
					<fpage>862</fpage>
					<lpage>875</lpage>
					<pub-id pub-id-type="pmid">11105913</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR105">
				<label>105.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Anderson</surname>
							<given-names>R. A.</given-names>
						</name>
						<name>
							<surname>Feathergill</surname>
							<given-names>K. A.</given-names>
						</name>
						<name>
							<surname>Diao</surname>
							<given-names>X. H.</given-names>
						</name>
						<name>
							<surname>Cooper</surname>
							<given-names>M. D.</given-names>
						</name>
						<name>
							<surname>Kirkpatrick</surname>
							<given-names>R.</given-names>
						</name>
						<name>
							<surname>Rencher</surname>
							<given-names>W. F.</given-names>
						</name>
						<name>
							<surname>Waller</surname>
							<given-names>D. P.</given-names>
						</name>
						<name>
							<surname>Chany</surname>
							<given-names>C. J.</given-names>
						</name>
						<name>
							<surname>Doncel</surname>
							<given-names>G. F.</given-names>
						</name>
						<name>
							<surname>Herold</surname>
							<given-names>B. C.</given-names>
						</name>
						<name>
							<surname>Zaneveld</surname>
							<given-names>L. J. D.</given-names>
						</name>
					</person-group>
					<article-title>Preclinical evaluation of sodium cellulose sulfate
						(Ushercell) as a contraceptive antimicrobial agent</article-title>
					<source>J. Androl.</source>
					<year>2002</year>
					<volume>23</volume>
					<fpage>426</fpage>
					<lpage>438</lpage>
					<pub-id pub-id-type="pmid">12002445</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR106">
				<label>106.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Christensen</surname>
							<given-names>N. D.</given-names>
						</name>
						<name>
							<surname>Reed</surname>
							<given-names>C. A.</given-names>
						</name>
						<name>
							<surname>Culp</surname>
							<given-names>T. D.</given-names>
						</name>
						<name>
							<surname>Hermonat</surname>
							<given-names>P. L.</given-names>
						</name>
						<name>
							<surname>Howett</surname>
							<given-names>M. K.</given-names>
						</name>
						<name>
							<surname>Anderson</surname>
							<given-names>R. A.</given-names>
						</name>
						<name>
							<surname>Zaneveld</surname>
							<given-names>L. J.</given-names>
						</name>
					</person-group>
					<article-title>Papillomavirus microbicidal activities of
						high-molecular-weight cellulose sulfate, dextran sulfate, and
						polystyrene sulfonate</article-title>
					<source>Antimicrob. Agents Chemother.</source>
					<year>2001</year>
					<volume>45</volume>
					<fpage>3427</fpage>
					<lpage>3432</lpage>
					<pub-id pub-id-type="doi">10.1128/AAC.45.12.3427-3432.2001</pub-id>
					<pub-id pub-id-type="pmid">11709319</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR107">
				<label>107.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Herold</surname>
							<given-names>B. C.</given-names>
						</name>
						<name>
							<surname>Bourne</surname>
							<given-names>N.</given-names>
						</name>
						<name>
							<surname>Marcellino</surname>
							<given-names>D.</given-names>
						</name>
						<name>
							<surname>Kirkpatrick</surname>
							<given-names>R.</given-names>
						</name>
						<name>
							<surname>Strauss</surname>
							<given-names>D. M.</given-names>
						</name>
						<name>
							<surname>Zaneveld</surname>
							<given-names>L. J.</given-names>
						</name>
						<name>
							<surname>Waller</surname>
							<given-names>D. P.</given-names>
						</name>
						<name>
							<surname>Anderson</surname>
							<given-names>R. A.</given-names>
						</name>
						<name>
							<surname>Chany</surname>
							<given-names>C. J.</given-names>
						</name>
						<name>
							<surname>Barham</surname>
							<given-names>B. J.</given-names>
						</name>
						<name>
							<surname>Stanberry</surname>
							<given-names>L. R.</given-names>
						</name>
						<name>
							<surname>Cooper</surname>
							<given-names>M. D.</given-names>
						</name>
					</person-group>
					<article-title>Poly (sodium 4-styrene sulfonate): an effective
						candidate topical antimicrobial for the prevention of sexually
						transmitted diseases</article-title>
					<source>J. Infect. Dis.</source>
					<year>2000</year>
					<volume>181</volume>
					<fpage>770</fpage>
					<lpage>773</lpage>
					<pub-id pub-id-type="doi">10.1086/315228</pub-id>
					<pub-id pub-id-type="pmid">10669374</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR108">
				<label>108.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Zaneveld</surname>
							<given-names>L. J.</given-names>
						</name>
						<name>
							<surname>Waller</surname>
							<given-names>D. P.</given-names>
						</name>
						<name>
							<surname>Anderson</surname>
							<given-names>R. A.</given-names>
						</name>
						<name>
							<surname>Chany</surname>
							<given-names>C.</given-names>
						</name>
						<name>
							<surname>Rencher</surname>
							<given-names>W. F.</given-names>
						</name>
						<name>
							<surname>Feathergill</surname>
							<given-names>K.</given-names>
						</name>
						<name>
							<surname>Diao</surname>
							<given-names>K.</given-names>
						</name>
						<name>
							<surname>Doncel</surname>
							<given-names>G. F.</given-names>
						</name>
						<name>
							<surname>Herold</surname>
							<given-names>B.</given-names>
						</name>
						<name>
							<surname>Cooper</surname>
							<given-names>M.</given-names>
						</name>
					</person-group>
					<article-title>Efficacy and safety of a new vaginal contraceptive
						antimicrobial formulation containing high molecular weight poly
						(sodium 4-styrenesulfonate)</article-title>
					<source>Biol. Reprod.</source>
					<year>2002</year>
					<volume>66</volume>
					<fpage>886</fpage>
					<lpage>894</lpage>
					<pub-id pub-id-type="doi">10.1095/biolreprod66.4.886</pub-id>
					<pub-id pub-id-type="pmid">11906905</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR109">
				<label>109.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Bourne</surname>
							<given-names>N.</given-names>
						</name>
						<name>
							<surname>Bernstein</surname>
							<given-names>D. L.</given-names>
						</name>
						<name>
							<surname>Ireland</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Sonderfan</surname>
							<given-names>A. J.</given-names>
						</name>
						<name>
							<surname>Profy</surname>
							<given-names>A. T.</given-names>
						</name>
						<name>
							<surname>Stanberry</surname>
							<given-names>L. R.</given-names>
						</name>
					</person-group>
					<article-title>The topical microbicides PRO 2000 protects against
						genital herpes infection in a mouse model</article-title>
					<source>J. Infect Dis.</source>
					<year>1999</year>
					<volume>180</volume>
					<fpage>203</fpage>
					<lpage>205</lpage>
					<pub-id pub-id-type="doi">10.1086/314853</pub-id>
					<pub-id pub-id-type="pmid">10353881</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR110">
				<label>110.</label>
				<mixed-citation publication-type="other">
					L. Highleyman. UsherCell microbicides provides no protection
					against HIV transmission but VivaGel yields promising early data.
					<italic>4th International Conference on HIV Treatment, Pathogenesis
						and Prevention, Sydney, Australia</italic>
					(2007).
				</mixed-citation>
			</ref>
			<ref id="CR111">
				<label>111.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Baba</surname>
							<given-names>M.</given-names>
						</name>
						<name>
							<surname>Schols</surname>
							<given-names>D.</given-names>
						</name>
						<name>
							<surname>Clercq</surname>
							<given-names>E.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Novel sulfated polymers as highly potent and
						selective inhibitors of human immunodeficiency virus replication
						and giant cell formation</article-title>
					<source>Antimicrob. Agents Chemother.</source>
					<year>1990</year>
					<volume>34</volume>
					<issue>1</issue>
					<fpage>134</fpage>
					<lpage>138</lpage>
					<pub-id pub-id-type="pmid">2327749</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR112">
				<label>112.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Balzarini</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Damme</surname>
							<given-names>L.</given-names>
						</name>
					</person-group>
					<article-title>Microbicide drug candidates to prevent HIV infection</article-title>
					<source>The Lancet</source>
					<year>2007</year>
					<volume>369</volume>
					<fpage>787</fpage>
					<lpage>797</lpage>
					<pub-id pub-id-type="doi">10.1016/S0140-6736(07)60202-5</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR113">
				<label>113.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Clercq</surname>
							<given-names>E.</given-names>
						</name>
					</person-group>
					<article-title>New anti-HIV agents in preclinical and clinical
						development</article-title>
					<source>Frontiers in Med Chem.</source>
					<year>2004</year>
					<volume>1</volume>
					<issue>1</issue>
					<fpage>543</fpage>
					<lpage>579</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR114">
				<label>114.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Morrow</surname>
							<given-names>K.</given-names>
						</name>
						<name>
							<surname>Rosen</surname>
							<given-names>R.</given-names>
						</name>
						<name>
							<surname>Ritcher</surname>
							<given-names>L.</given-names>
						</name>
						<name>
							<surname>Emans</surname>
							<given-names>A.</given-names>
						</name>
						<name>
							<surname>Forbes</surname>
							<given-names>A.</given-names>
						</name>
						<name>
							<surname>Day</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Morar</surname>
							<given-names>N.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>The acceptability of an investigational vaginal
						microbicide, PRO 2000 Gel, among women in a phase I clinical trial</article-title>
					<source>J. Women&#x02019;s Health</source>
					<year>2003</year>
					<volume>12</volume>
					<issue>7</issue>
					<fpage>655</fpage>
					<lpage>666</lpage>
					<pub-id pub-id-type="doi">10.1089/154099903322404302</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR115">
				<label>115.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Joshi</surname>
							<given-names>S. N.</given-names>
						</name>
						<name>
							<surname>Dutta</surname>
							<given-names>S.</given-names>
						</name>
						<name>
							<surname>Bell</surname>
							<given-names>B.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Phase I safety study of 0.5% PRO 2000 vaginal gel
						among HIV un-infected women in Pune, India</article-title>
					<source>AIDS Res. Ther.</source>
					<year>2006</year>
					<volume>3</volume>
					<issue>4</issue>
					<fpage>2</fpage>
					<lpage>6</lpage>
					<pub-id pub-id-type="pmid">16417638</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR116">
				<label>116.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ruscnis</surname>
							<given-names>S.</given-names>
						</name>
						<name>
							<surname>Moonis</surname>
							<given-names>M.</given-names>
						</name>
						<name>
							<surname>Merril</surname>
							<given-names>D. P.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Naphtalene sulfonate polymers with CD4-blocking and
						anti-human immunodeficiency virus type 1 activities</article-title>
					<source>Antimicrob. Agents Chemother.</source>
					<year>1996</year>
					<volume>40</volume>
					<fpage>234</fpage>
					<pub-id pub-id-type="pmid">8787913</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR117">
				<label>117.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Damme</surname>
							<given-names>L.</given-names>
						</name>
						<name>
							<surname>Wright</surname>
							<given-names>A.</given-names>
						</name>
						<name>
							<surname>Depraetene</surname>
							<given-names>K.</given-names>
						</name>
					</person-group>
					<article-title>A phase I study of a novel potential intravaginal
						microbicides, PRO 2000, in healthy sexually inactive women</article-title>
					<source>Sex. Transm. Infect.</source>
					<year>2000</year>
					<volume>76</volume>
					<fpage>126</fpage>
					<pub-id pub-id-type="doi">10.1136/sti.76.2.126</pub-id>
					<pub-id pub-id-type="pmid">10858715</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR118">
				<label>118.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Smith</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Soma</surname>
							<given-names>D.</given-names>
						</name>
						<name>
							<surname>Beverly</surname>
							<given-names>B.</given-names>
						</name>
						<name>
							<surname>Albert</surname>
							<given-names>P.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Phase I safety study of 0.5% PRO 2000 vaginal gel
						among HIV un-infected women in Pune, India</article-title>
					<source>AIDS Res. Ther.</source>
					<year>2006</year>
					<volume>3</volume>
					<fpage>4</fpage>
					<pub-id pub-id-type="doi">10.1186/1742-6405-3-4</pub-id>
					<pub-id pub-id-type="pmid">16504023</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR119">
				<label>119.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mayer</surname>
							<given-names>K. H.</given-names>
						</name>
						<name>
							<surname>Karim</surname>
							<given-names>S. A.</given-names>
						</name>
						<name>
							<surname>Kelly</surname>
							<given-names>C.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>The safety and tolerability of a novel vaginal
						microbicides, PRO 2000/5Gel, in sexually active HIV-uninfected and
						abstinent HIV-infected women</article-title>
					<source>AIDS</source>
					<year>2003</year>
					<volume>17</volume>
					<fpage>321</fpage>
					<pub-id pub-id-type="doi">10.1097/00002030-200302140-00005</pub-id>
					<pub-id pub-id-type="pmid">12556685</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR120">
				<label>120.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Manson</surname>
							<given-names>K. H.</given-names>
						</name>
						<name>
							<surname>Wyand</surname>
							<given-names>M. S.</given-names>
						</name>
						<name>
							<surname>Miller</surname>
							<given-names>C.</given-names>
						</name>
						<name>
							<surname>Neurath</surname>
							<given-names>A. R.</given-names>
						</name>
					</person-group>
					<article-title>Effect of cellulose acetate phthalate topical cream
						on vaginal transmission of simian immunodeficiency virus in rhesus
						monkeys</article-title>
					<source>Antimicrob. Agents Chemother.</source>
					<year>2000</year>
					<volume>44</volume>
					<issue>11</issue>
					<fpage>3199</fpage>
					<lpage>3302</lpage>
					<pub-id pub-id-type="doi">10.1128/AAC.44.11.3199-3202.2000</pub-id>
					<pub-id pub-id-type="pmid">11036053</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR121">
				<label>121.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Neurath</surname>
							<given-names>A. R.</given-names>
						</name>
						<name>
							<surname>Srick</surname>
							<given-names>N.</given-names>
						</name>
						<name>
							<surname>Li</surname>
							<given-names>Y.</given-names>
						</name>
					</person-group>
					<article-title>Water dispersible microbicidal cellulose acetate
						phthalate film</article-title>
					<source>BMC Infect. Dis.</source>
					<year>2003</year>
					<volume>3</volume>
					<fpage>27</fpage>
					<pub-id pub-id-type="doi">10.1186/1471-2334-3-27</pub-id>
					<pub-id pub-id-type="pmid">14617380</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR122">
				<label>122.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Fichora</surname>
							<given-names>R. N.</given-names>
						</name>
						<name>
							<surname>Zhou</surname>
							<given-names>F.</given-names>
						</name>
						<name>
							<surname>Ratnan</surname>
							<given-names>V.</given-names>
						</name>
						<name>
							<surname>Atanassova</surname>
							<given-names>V.</given-names>
						</name>
						<name>
							<surname>Giang</surname>
							<given-names>S.</given-names>
						</name>
						<name>
							<surname>Strick</surname>
							<given-names>N.</given-names>
						</name>
						<name>
							<surname>Neurath</surname>
							<given-names>A. R.</given-names>
						</name>
					</person-group>
					<article-title>
						Anti-human immunodeficiency virus type I microbicides cellulose
						acetate 1,2-benzene dicarbxylate in a human
						<italic>in vitro</italic>
						model of vaginal inflammation
					</article-title>
					<source>Antimicrob. Agents Chemother.</source>
					<year>2005</year>
					<volume>49</volume>
					<issue>1</issue>
					<fpage>323</fpage>
					<lpage>325</lpage>
					<pub-id pub-id-type="doi">10.1128/AAC.49.1.323-335.2005</pub-id>
					<pub-id pub-id-type="pmid">15616312</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR123">
				<label>123.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Thormar</surname>
							<given-names>H.</given-names>
						</name>
						<name>
							<surname>Bergsson</surname>
							<given-names>G.</given-names>
						</name>
						<name>
							<surname>Gunnarsson</surname>
							<given-names>E.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Hydrogels containing monocaprin have potent
						microbicidal activities against sexually transmitted viruses and
						bacteria in vitro</article-title>
					<source>Sex. Transm. Infect.</source>
					<year>1999</year>
					<volume>75</volume>
					<issue>3</issue>
					<fpage>181</fpage>
					<lpage>185</lpage>
					<pub-id pub-id-type="doi">10.1136/sti.75.3.181</pub-id>
					<pub-id pub-id-type="pmid">10448397</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR124">
				<label>124.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Neyts</surname>
							<given-names>K. T. J.</given-names>
						</name>
						<name>
							<surname>Clercq</surname>
							<given-names>E.</given-names>
						</name>
						<name>
							<surname>Thormar</surname>
							<given-names>H.</given-names>
						</name>
					</person-group>
					<article-title>Hydrogels containing monocaprin prevent intravaginal
						and intracutaneous infections with HSV-2 in mice: Impact on the
						search for vaginal microbicides</article-title>
					<source>J. Med. Virol.</source>
					<year>2000</year>
					<volume>61</volume>
					<issue>1</issue>
					<fpage>107</fpage>
					<lpage>110</lpage>
					<pub-id pub-id-type="doi">10.1002/(SICI)1096-9071(200005)61:1&#x0003c;107::AID-JMV17&#x0003e;3.0.CO;2-W</pub-id>
					<pub-id pub-id-type="pmid">10745241</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR125">
				<label>125.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kristmundsd&#x000f3;ttir</surname>
							<given-names>T.</given-names>
						</name>
						<name>
							<surname>&#x000c1;rnad&#x000f3;ttir</surname>
							<given-names>S. G.</given-names>
						</name>
						<name>
							<surname>Bergsson</surname>
							<given-names>G.</given-names>
						</name>
						<name>
							<surname>Thormar</surname>
							<given-names>H.</given-names>
						</name>
					</person-group>
					<article-title>Development and evaluation of microbicidal hydrogels
						containing monoglyceride as the active ingredient</article-title>
					<source>J. Pharm. Sci.</source>
					<year>2000</year>
					<volume>88</volume>
					<issue>10</issue>
					<fpage>1011</fpage>
					<lpage>1015</lpage>
					<pub-id pub-id-type="doi">10.1021/js9900396</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR126">
				<label>126.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Maggi</surname>
							<given-names>L.</given-names>
						</name>
						<name>
							<surname>Mastromarino</surname>
							<given-names>P.</given-names>
						</name>
						<name>
							<surname>Macchia</surname>
							<given-names>S.</given-names>
						</name>
						<name>
							<surname>Brigidi</surname>
							<given-names>P.</given-names>
						</name>
						<name>
							<surname>Pirovano</surname>
							<given-names>F.</given-names>
						</name>
						<name>
							<surname>Matteuzzi</surname>
							<given-names>D.</given-names>
						</name>
						<name>
							<surname>Conte</surname>
							<given-names>U.</given-names>
						</name>
					</person-group>
					<article-title>Technological and biological evaluation of tablets
						containing different strains of lactobacilli for vaginal
						administration</article-title>
					<source>Eur. J. Pharm. Biopharm.</source>
					<year>2000</year>
					<volume>50</volume>
					<fpage>389</fpage>
					<lpage>395</lpage>
					<pub-id pub-id-type="doi">10.1016/S0939-6411(00)00121-1</pub-id>
					<pub-id pub-id-type="pmid">11072196</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR127">
				<label>127.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Krebs</surname>
							<given-names>F. C.</given-names>
						</name>
						<name>
							<surname>Miller</surname>
							<given-names>R. S.</given-names>
						</name>
						<name>
							<surname>Catalone</surname>
							<given-names>B. J.</given-names>
						</name>
						<name>
							<surname>Welsh</surname>
							<given-names>P. A.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Sodium dodecyl sulfate and C31G as microbicidal
						alternatives to nonoxynol 9): Comparative sensitivity of primary
						human vaginal keratinocytes</article-title>
					<source>Antimicrob. Agents Chemother.</source>
					<year>2000</year>
					<volume>44</volume>
					<issue>7</issue>
					<fpage>1954</fpage>
					<lpage>1960</lpage>
					<pub-id pub-id-type="doi">10.1128/AAC.44.7.1954-1960.2000</pub-id>
					<pub-id pub-id-type="pmid">10858360</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR128">
				<label>128.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Gadi</surname>
							<given-names>B.</given-names>
						</name>
						<name>
							<surname>Parniak</surname>
							<given-names>M. A.</given-names>
						</name>
					</person-group>
					<article-title>Anti-HIV-1 microbicide potential of the
						tight-binding non-nucleoside reverse transcriptase inhibitor UC781</article-title>
					<source>AIDScience</source>
					<year>2001</year>
					<volume>1</volume>
					<fpage>12</fpage>
				</mixed-citation>
			</ref>
			<ref id="CR129">
				<label>129.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kerr</surname>
							<given-names>M.</given-names>
						</name>
					</person-group>
					<article-title>NNRTI shows safety as a topical anti-HIV microbicide
						in animal tests</article-title>
					<source>Antimicrob. Agents Chemother.</source>
					<year>2007</year>
					<volume>51</volume>
					<fpage>1608</fpage>
					<lpage>1615</lpage>
					<pub-id pub-id-type="doi">10.1128/AAC.00984-06</pub-id>
					<pub-id pub-id-type="pmid">17353240</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR130">
				<label>130.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Clercq</surname>
							<given-names>E.</given-names>
						</name>
					</person-group>
					<article-title>The role of tenofovir in the prevention of HIV
						infections</article-title>
					<source>AIDS</source>
					<year>2006</year>
					<volume>20</volume>
					<issue>15</issue>
					<fpage>1990</fpage>
					<lpage>1991</lpage>
					<pub-id pub-id-type="doi">10.1097/01.aids.0000247128.27505.28</pub-id>
					<pub-id pub-id-type="pmid">16988528</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR131">
				<label>131.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>D&#x02019;Cruz</surname>
							<given-names>O. J.</given-names>
						</name>
					</person-group>
					<article-title>Stampidine is a potential nonspermicidal
						broad-spectrum anti-human immunodeficiency virus microbicides</article-title>
					<source>Fertil. Steril.</source>
					<year>2003</year>
					<volume>81</volume>
					<fpage>831</fpage>
					<lpage>841</lpage>
					<pub-id pub-id-type="doi">10.1016/j.fertnstert.2003.08.037</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR132">
				<label>132.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>D&#x02019;Cruz</surname>
							<given-names>O. J.</given-names>
						</name>
						<name>
							<surname>Samuel</surname>
							<given-names>P.</given-names>
						</name>
						<name>
							<surname>Waurzyniak</surname>
							<given-names>B.</given-names>
						</name>
						<name>
							<surname>Uckun</surname>
							<given-names>F. M.</given-names>
						</name>
					</person-group>
					<article-title>
						<italic>In vivo</italic>
						evaluation of a gel formulation of stampidine, a novel
						non-spermicidal broad-spectrum anti-HIV microbicide
					</article-title>
					<source>Am. J. Drug Deliv.</source>
					<year>2003</year>
					<volume>1</volume>
					<issue>4</issue>
					<fpage>275</fpage>
					<lpage>285</lpage>
					<pub-id pub-id-type="doi">10.2165/00137696-200301040-00006</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR133">
				<label>133.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Boyd</surname>
							<given-names>M. R.</given-names>
						</name>
						<name>
							<surname>Gustfson</surname>
							<given-names>K. R.</given-names>
						</name>
						<name>
							<surname>Mc Mahon</surname>
							<given-names>J. B.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Discovery of cyanovirin-N, a novel human
						immunodeficiency virus-ianactivating protein that binds viral
						surface envelope glycoprotein gp 120: potential application to
						microbicide development</article-title>
					<source>Antimicrob. Agents Chemother.</source>
					<year>1997</year>
					<volume>41</volume>
					<fpage>1521</fpage>
					<lpage>1530</lpage>
					<pub-id pub-id-type="pmid">9210678</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR134">
				<label>134.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Clercq</surname>
							<given-names>E.</given-names>
						</name>
					</person-group>
					<article-title>Current lead natural products for the chemotherapy
						of human immunodeficiency virus (HIV) infection</article-title>
					<source>Med. Res. Rev.</source>
					<year>2000</year>
					<volume>20</volume>
					<fpage>323</fpage>
					<lpage>349</lpage>
					<pub-id pub-id-type="doi">10.1002/1098-1128(200009)20:5&#x0003c;323::AID-MED1&#x0003e;3.0.CO;2-A</pub-id>
					<pub-id pub-id-type="pmid">10934347</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR135">
				<label>135.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Balzarini</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Hatse</surname>
							<given-names>S.</given-names>
						</name>
						<name>
							<surname>Vermeire</surname>
							<given-names>K.</given-names>
						</name>
						<name>
							<surname>Princen</surname>
							<given-names>K.</given-names>
						</name>
						<name>
							<surname>Aquaro</surname>
							<given-names>S.</given-names>
						</name>
						<name>
							<surname>Perno</surname>
							<given-names>C. F.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Mannose-specific plant lectins from the
						Amaryllidaceae family qualify as efficient microbicides for
						prevention of human immunodeficiency virus infection</article-title>
					<source>Antimicrob. Agents Chemother.</source>
					<year>2004</year>
					<volume>48</volume>
					<fpage>3858</fpage>
					<lpage>3870</lpage>
					<pub-id pub-id-type="doi">10.1128/AAC.48.10.3858-3870.2004</pub-id>
					<pub-id pub-id-type="pmid">15388446</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR136">
				<label>136.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Balzarini</surname>
							<given-names>J.</given-names>
						</name>
					</person-group>
					<article-title>Targeting the glycans of gp120: a novel approach
						aimed at the achilles heel of HIV</article-title>
					<source>Lancet Infect. Dis.</source>
					<year>2005</year>
					<volume>5</volume>
					<fpage>726</fpage>
					<lpage>731</lpage>
					<pub-id pub-id-type="doi">10.1016/S1473-3099(05)70271-1</pub-id>
					<pub-id pub-id-type="pmid">16253890</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR137">
				<label>137.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Tsai</surname>
							<given-names>C. C.</given-names>
						</name>
						<name>
							<surname>Emau</surname>
							<given-names>P.</given-names>
						</name>
						<name>
							<surname>Jiang</surname>
							<given-names>Y.</given-names>
						</name>
						<name>
							<surname>Tian</surname>
							<given-names>B.</given-names>
						</name>
						<name>
							<surname>Morton</surname>
							<given-names>W. R.</given-names>
						</name>
						<name>
							<surname>Gustafson</surname>
							<given-names>K. R.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Cyanovirin-N gel as a topical microbicide prevents
						rectal transmission of SHIV89.6P in macaques</article-title>
					<source>AIDS Res. Hum. Retrovir.</source>
					<year>2003</year>
					<volume>19</volume>
					<fpage>535</fpage>
					<lpage>541</lpage>
					<pub-id pub-id-type="doi">10.1089/088922203322230897</pub-id>
					<pub-id pub-id-type="pmid">12921090</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR138">
				<label>138.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Xiaowen</surname>
							<given-names>L.</given-names>
						</name>
						<name>
							<surname>Lagenaur</surname>
							<given-names>L. A.</given-names>
						</name>
						<name>
							<surname>Simpson</surname>
							<given-names>D. A.</given-names>
						</name>
					</person-group>
					<article-title>Engineered vaginal Lactobacillus strain for mucosal
						delivery of the human immunodeficiency virus inhibitor
						cyanovirin-N</article-title>
					<source>Antimicrob. Agents Chemother.</source>
					<year>2006</year>
					<volume>50</volume>
					<issue>10</issue>
					<fpage>3250</fpage>
					<lpage>3259</lpage>
					<pub-id pub-id-type="doi">10.1128/AAC.00493-06</pub-id>
					<pub-id pub-id-type="pmid">17005802</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR139">
				<label>139.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>O&#x02019; Keef</surname>
							<given-names>B. R.</given-names>
						</name>
					</person-group>
					<article-title>Biologically active proteins from natural product
						extracts</article-title>
					<source>J. Nat. Prod.</source>
					<year>2001</year>
					<volume>64</volume>
					<fpage>1373</fpage>
					<lpage>1381</lpage>
					<pub-id pub-id-type="doi">10.1021/np0103362</pub-id>
					<pub-id pub-id-type="pmid">11678673</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR140">
				<label>140.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ward</surname>
							<given-names>R. L.</given-names>
						</name>
						<name>
							<surname>Ashley</surname>
							<given-names>C. S.</given-names>
						</name>
					</person-group>
					<article-title>pH modification of the effects of detergents on the
						stability of enteric viruses</article-title>
					<source>Appl. Environ. Microbiol.</source>
					<year>1979</year>
					<volume>38</volume>
					<fpage>314</fpage>
					<lpage>322</lpage>
					<pub-id pub-id-type="pmid">42351</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR141">
				<label>141.</label>
				<mixed-citation publication-type="other">
					S. Roy, J. Piret, N. Gagne
					<italic>et al</italic>
					. Thermoreversible gel containing sodium lauryl sulfate as a
					potential topical microbicide for the prevention of STDs/HIV.
					<italic>Natl HIV Prev Conf Natl HIV Prev Conf., Atlanta GA</italic>
					1999.
				</mixed-citation>
			</ref>
			<ref id="CR142">
				<label>142.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Piret</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Lamontagne</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Bestman-Smith</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Roy</surname>
							<given-names>S.</given-names>
						</name>
						<name>
							<surname>Gourde</surname>
							<given-names>P.</given-names>
						</name>
						<name>
							<surname>D&#x000e9;sormeaux</surname>
							<given-names>A.</given-names>
						</name>
						<name>
							<surname>Omar</surname>
							<given-names>R. F.</given-names>
						</name>
						<name>
							<surname>Juh&#x000e1;sz</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Bergeron</surname>
							<given-names>M. G.</given-names>
						</name>
					</person-group>
					<article-title>
						<italic>In vitro</italic>
						and
						<italic>in vivo</italic>
						evaluations of sodium lauryl sulfate and dextran sulfate as
						microbicides against herpes simplex and human immunodeficiency
						viruses
					</article-title>
					<source>J. Clin. Microbiol.</source>
					<year>2000</year>
					<volume>38</volume>
					<fpage>110</fpage>
					<lpage>119</lpage>
					<pub-id pub-id-type="pmid">10618073</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR143">
				<label>143.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Howett</surname>
							<given-names>M. K.</given-names>
						</name>
						<name>
							<surname>Neely</surname>
							<given-names>E. B.</given-names>
						</name>
						<name>
							<surname>Christensen</surname>
							<given-names>N. D.</given-names>
						</name>
						<name>
							<surname>Wigdahl</surname>
							<given-names>B.</given-names>
						</name>
						<name>
							<surname>Krebs</surname>
							<given-names>F. C.</given-names>
						</name>
						<name>
							<surname>Malamud</surname>
							<given-names>D.</given-names>
						</name>
						<name>
							<surname>Patrick</surname>
							<given-names>S. D.</given-names>
						</name>
						<name>
							<surname>Pickel</surname>
							<given-names>M. D.</given-names>
						</name>
						<name>
							<surname>Welsh</surname>
							<given-names>P. A.</given-names>
						</name>
						<name>
							<surname>Reed</surname>
							<given-names>C. A.</given-names>
						</name>
						<name>
							<surname>Ward</surname>
							<given-names>M. G.</given-names>
						</name>
						<name>
							<surname>Budgeon</surname>
							<given-names>L. R.</given-names>
						</name>
						<name>
							<surname>Kreider</surname>
							<given-names>J. W.</given-names>
						</name>
					</person-group>
					<article-title>A broad-spectrum microbicide with virucidal activity
						against sexually transmitted viruses</article-title>
					<source>Antimicrob. Agents Chemother.</source>
					<year>1999</year>
					<volume>43</volume>
					<fpage>314</fpage>
					<lpage>321</lpage>
					<pub-id pub-id-type="doi">10.1093/jac/43.2.314</pub-id>
					<pub-id pub-id-type="pmid">9925525</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR144">
				<label>144.</label>
				<mixed-citation publication-type="other">
					M. Smith. TMC 120 vaginal ring promising as microbicides carrier.
					<italic>XVI International Conference, Toronto Canada</italic>
					, 2006.
				</mixed-citation>
			</ref>
			<ref id="CR145">
				<label>145.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Nutall</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Romano</surname>
							<given-names>J.</given-names>
						</name>
						<name>
							<surname>Douville</surname>
							<given-names>K.</given-names>
						</name>
					</person-group>
					<article-title>The future of HIV prevention: Prospects of an
						effective anti-HIV microbicide</article-title>
					<source>Infect. Dis. Clin. North Am.</source>
					<year>2007</year>
					<volume>21</volume>
					<fpage>219</fpage>
					<lpage>239</lpage>
					<pub-id pub-id-type="doi">10.1016/j.idc.2007.01.009</pub-id>
					<pub-id pub-id-type="pmid">17502237</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR146">
				<label>146.</label>
				<mixed-citation publication-type="other">
					Molecular trees bear fruit. Vogtle. Available at:
					<ext-link ext-link-type="uri"
						xlink:href="http://www.rsc.org/chemistryworld/restricted/2007/May/MolecularTreesBearFruit.asp">http://www.rsc.org/chemistryworld/restricted/2007/May/MolecularTreesBearFruit.asp</ext-link>
					. Accessed June 9, 2007.
				</mixed-citation>
			</ref>
			<ref id="CR147">
				<label>147.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Jiang</surname>
							<given-names>Y.</given-names>
						</name>
						<name>
							<surname>Emau</surname>
							<given-names>P.</given-names>
						</name>
						<name>
							<surname>Cairns</surname>
							<given-names>J. S.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>SPL7013 gel as a topical microbicide for prevention
						of vaginal transmission of SHIV in macaques</article-title>
					<source>AIDS Res. Hum. Retrovir.</source>
					<year>2005</year>
					<volume>21</volume>
					<issue>3</issue>
					<fpage>207</fpage>
					<lpage>213</lpage>
					<pub-id pub-id-type="doi">10.1089/aid.2005.21.207</pub-id>
					<pub-id pub-id-type="pmid">15795526</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR148">
				<label>148.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Bernstein</surname>
							<given-names>D. I.</given-names>
						</name>
						<name>
							<surname>Stanberry</surname>
							<given-names>L. R.</given-names>
						</name>
						<name>
							<surname>Sacks</surname>
							<given-names>S.</given-names>
						</name>
						<etal />
					</person-group>
					<article-title>Evaluations of unformulated and formulated
						dendrimer-based microbicide candidates in mouse and guinea pig
						models of genital herpes</article-title>
					<source>Antimicrob. Agents Chemother.</source>
					<year>2003</year>
					<volume>47</volume>
					<issue>12</issue>
					<fpage>3784</fpage>
					<lpage>3788</lpage>
					<pub-id pub-id-type="doi">10.1128/AAC.47.12.3784-3788.2003</pub-id>
					<pub-id pub-id-type="pmid">14638483</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR160">
				<label>160.</label>
				<mixed-citation publication-type="other">
					Microbicides trials get London start.
					<italic>Prevention.</italic>
					Cairns G. Available at:
					<ext-link ext-link-type="uri" xlink:href="http://www.guscairns.com/">http://www.guscairns.com/</ext-link>
					. Accessed July 23, 2007.
				</mixed-citation>
			</ref>
			<ref id="CR163">
				<label>163.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Castle</surname>
							<given-names>P. E.</given-names>
						</name>
						<name>
							<surname>Whaley</surname>
							<given-names>K. J.</given-names>
						</name>
						<name>
							<surname>Hoen</surname>
							<given-names>T. E.</given-names>
						</name>
						<name>
							<surname>Moench</surname>
							<given-names>T. R.</given-names>
						</name>
						<name>
							<surname>Cone</surname>
							<given-names>R. A.</given-names>
						</name>
					</person-group>
					<article-title>Contraceptive effect of sperm-agglutinating
						monoclonal antibodies in rabbits</article-title>
					<source>Biol. Reprod.</source>
					<year>1997</year>
					<volume>56</volume>
					<fpage>53</fpage>
					<lpage>159</lpage>
					<pub-id pub-id-type="doi">10.1095/biolreprod56.1.153</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR170">
				<label>170.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Crombie</surname>
							<given-names>R.</given-names>
						</name>
						<name>
							<surname>Kawasaki</surname>
							<given-names>K.</given-names>
						</name>
						<name>
							<surname>Hojo</surname>
							<given-names>K.</given-names>
						</name>
						<name>
							<surname>Laurence</surname>
							<given-names>J.</given-names>
						</name>
					</person-group>
					<article-title>Peptides derived from salivary thrombospondin-1
						replicate its anti-HIV effect: Potential role in microbicide
						development</article-title>
					<source>J. AIDS</source>
					<year>2001</year>
					<volume>27</volume>
					<issue>1</issue>
					<fpage>91</fpage>
					<lpage>93</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR171">
				<label>171.</label>
				<mixed-citation publication-type="other">
					Adams
					<italic>et al</italic>
					. (1995)
				</mixed-citation>
			</ref>
			<ref id="CR172">
				<label>172.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Bornstein</surname>
							<given-names>P.</given-names>
						</name>
					</person-group>
					<article-title>Diversity of function is inherent in matricellular
						proteins: an appraisal of thrombospondin-1</article-title>
					<source>J. Cell Biol.</source>
					<year>1995</year>
					<volume>130</volume>
					<fpage>503</fpage>
					<lpage>506</lpage>
					<pub-id pub-id-type="doi">10.1083/jcb.130.3.503</pub-id>
					<pub-id pub-id-type="pmid">7542656</pub-id>
				</mixed-citation>
			</ref>
			<ref id="CR173">
				<label>173.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Roumeliotis</surname>
							<given-names>G.</given-names>
						</name>
					</person-group>
					<article-title>SR Pharma claims formulation triumph in siRNA drugs</article-title>
					<source>Alliance for Microbicide Development</source>
					<year>2006</year>
					<volume>73</volume>
					<issue>5</issue>
					<fpage>542</fpage>
					<lpage>547</lpage>
				</mixed-citation>
			</ref>
			<ref id="CR174">
				<label>174.</label>
				<mixed-citation publication-type="other">
					P. Cristofaro, and B. Ramratnam.
					<italic>Prevention Strategies: Vaccines and Microbicides 12th
						Conference on Retrovirus and Opportunistic Infections</italic>
					. Boston, USA, 2005, pp. 22&#x02013;25.
				</mixed-citation>
			</ref>
			<ref id="CR175">
				<label>175.</label>
				<mixed-citation publication-type="other">
					M. Potts, D. Perlman, M. Mandara, N. Prata, and M. Campbell. Is
					lime/lemon juice an effective microbicide?
					<italic>Int Conf AIDS, University of California, Berkeley, CA,
						United States</italic>
					, 2004. Abstract C11663.
				</mixed-citation>
			</ref>
			<ref id="CR176">
				<label>176.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Turpin</surname>
							<given-names>J.</given-names>
						</name>
					</person-group>
					<article-title>Yoghurt could help fend off HIV</article-title>
					<source>New Scientist Magazine</source>
					<year>2006</year>
					<volume>17</volume>
					<fpage>2572</fpage>
				</mixed-citation>
			</ref>
			<ref id="CR177">
				<label>177.</label>
				<mixed-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Voravuthikunchai</surname>
							<given-names>S. P.</given-names>
						</name>
						<name>
							<surname>Bilasoi</surname>
							<given-names>S.</given-names>
						</name>
						<name>
							<surname>Supamala</surname>
							<given-names>O.</given-names>
						</name>
					</person-group>
					<article-title>Antagonistic activity against pathogenic bacteria by
						human vaginal lactobacilli</article-title>
					<source>Anaerobe</source>
					<year>2006</year>
					<volume>12</volume>
					<fpage>221</fpage>
					<lpage>226</lpage>
					<pub-id pub-id-type="doi">10.1016/j.anaerobe.2006.06.003</pub-id>
					<pub-id pub-id-type="pmid">16931064</pub-id>
				</mixed-citation>
			</ref>
		</ref-list>
	</back>
</article>